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ABSTRACT
PROPERTIES OF TERATOCARCINOMA SOMATIC CELL HYBRIDS
Richard A. Miller 
Yale University 1977
This dissertation describes the production and characterization of two 
series of somatic cell hybrids. PCT hybrids result from the fusion of 
mouse thymocytes with PCC4azal embryonal carcinoma cells (pluripotent 
cells derived from a mouse teratocarcinoma)< PCF hybrids arise from the 
fusion of PCC4azal with FBU, a line of Friend erythroleukemia cells.
These hybrid cells resemble their embryonal carcinoma parents in many 
ways. They look like PCC4azal by phase contrast and electron microscopy.
Like embryonal carcinoma cells, they have high levels of alkaline phosphatase. 
They are resistant to infection by a parvovirus, MVM, which can infect many 
mouse cell lines, but not embryonal carcinoma cells. The hybrids also 
produce tumors which contain a variety of cell types, including derivatives 
of all three of the classical germ layers. The most highly-differentiated 
tumors produce mouse a-fetoprotein.
Traits characteristic of the non-pluripotent parental cell line, such 
as Thy-1 antigen in thymocytes, and acetylcholinesterase in Friend cells, 
are not expressed in the hybrid cells. PCC4azal and FBU also differ in their 
pattern of lactate dehydrogenase isozymes, and the PCF cells resemble 
PCC4azal in this respect, too. PCF populations, unlike those of FBU, 
do not contain hemoglobinated cells.
At least some of the cells in PCT populations do, however, exhibit H-2
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antigens, which are expressed only at very low levels, if at all, in the 
PCC4azal parental cells.
These experiments show that although embryonal carcinoma cells can, 
under appropriate developmental conditions, give rise to thymocytes and 
erythroblasts, the genome of the pluripotent cell does not respond to 
the signals that these two differentiated cell types use to maintain 
their stable epigenetic state. On the contrary, pluripotent cells may 
contain a molecular mechanism able to "reset" the genetic apparatus of a 
differentiated cell.
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A Note on Terminology
I wish to state here how I intend to use certain terms often employed 
by other writers in diverse ways.
Teratoma, teratocarcinoma, embryonal carcinoma, embryoma: I intend
to use these terms in the ways suggested by Damjanov and Solter (1974), and 
by Stevens and Pierce (1975). Teratocarcinomas are transplantable tumors 
which contain cells of many different tissue types. Some of the cells in 
teratocarcinoma.?: are embryonal carcinoma cells, which are thought to render 
the tumor transplantable, and are thought to be the cell type from which all 
the other types are derived. The word "teratoma" is commonly used in two 
senses: first, to denote a teratocarcinoma-like tumor which is not, however, 
transplantable (because it contains no embryonal carcinoma cells); and second, 
as a lumping term which includes both the transplantable and non-transplant- 
able varieties. I shall use the word in both senses, and use the phrase 
"benign teratoma" when clarity requires it. Embryomas are growths which, 
like teratomas, contain a variety of cell types, but do not have the potential 
to grow continuously and never have contained embryonal carcinoma cells. 
Embryomas can be produced experimentally by the ectopic implantation of mouse 
embryos after the developmental stage at which transplantable teratocarcinomas 
can last be produced.
Embryo versus conceptus: strictly speaking, the conceptus includes both
the embryo proper and the extra-embryonic membranes. I shall, however, use 
the word "embryo" as synonymous with "conceptus," and the phrase "embryo 
proper" when distinction from extra-embryonic membranes is needed.
Malignant, transplantable, transformed, tumorigenic: to call tumors
transplantable, and cells tumorigenic, gives no one any trouble, since the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Xterms are operational. I shall avoid the term "transformed" unless it is 
clear what is being transformed by what. It is, for example, by no means 
clear that embryonal carcinoma cells, although tumorigenic, have undergone 
any sort of transformation. Some people use "malignant" to mean "meta­
stasizing," and others as a synonym for "transplantable;" I shall avoid 
its use.
Pluripotent, determined, differentiated: the confusion these terms
evoke reflects, in part, our ignorance of the decision-making process within 
the embryo. I will restrict the use of "pluripotent" to those cells which can 
give rise to several kinds of fundamentally different cells. Friend cells are 
not, in this sense, pluripotent, even though they can give rise to normoblast­
like cells different in many ways from ordinary Friend erythroblastoid cells.
I consider a cell "determined" or "committed" when it has entered into that 
ill-defined state from which it can, under ill-defined "normal" conditions, 
produce only the limited variety of cell types towards which it has just become 
determined. We know, since leukocyte albumin genes can be activated under some 
conditions (e.g. Darlington et al., 1974), that abnormal conditions can undo 
the effects of determination. I will not fall for the etymological cavil 
that says "all cells are differentiated" just because they all look different.
A differentiated cell, as I shall use the term, is one that has attained a 
state in which it remains stable within limits defined by the cell cycle (if 
still dividing) and modulating influences (e.g. hormones). A stem cell, all 
of whose progeny are either stem cells or (e.g.) epidermal cells, is determined 
but not yet differentiated. In the past, many somatic cell geneticists have 
called some particular cell line (usually fibroblastoid) "undifferentiated" 
because these cells were unlike the differentiated cell line with which they 
were being compared or fused. I do not use the term in this way; when one 
fuses a fibroblast with an embryonal carcinoma cell, it makes little sense to 
call the former cell undifferentiated.
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LIST OF ABBREVIATIONS
AChE: acetylcholinesterase
APase: alkaline phosphatase 
C?: complement
DMSO: dimethyl sulfoxide
DVME: Dulbecco-Vogt modified Eagle's medium
DVME-FC: DVME with 10% fetal calf serum
DVME-HAT: DVME with HAT additives
DVME-o: DVME without any additives (except antibiotics)
ECC: embryonal carcinoma cell
EDTA: ethylene diamine tetra-acetate
FBU: a line of BrdU-resistant Friend erythroleukemic cells
FCS: fetal calf serum
GPI: glucose phosphate isomerase
HAT: a mixture of hypo-:anthine, aminopterin and thymidine; concentrations
are given in the text 
IDH: isocitrate dehydrogenase
LDH: lactate dehydrogenase
MOI: multiplicity of infection
MPC: mesectodermal precursor cell
MVM: minute virus of mice
PCC4azal: an azaguanine-resistant embryonal carcinoma cell line
PCF: a line of PCC4azal x FBU hybrids
PCT: a line of PCC4azal x thymocyte hybrids
PFU: plaque-forming units
PGC: primordial germ cells
PGM: phosphoglucomutase
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"Ifm worried about Paul," Martha said.
"Hasn’t he done this kind of thing before?" Helen essayed a reassuring 
laugh. "I’d gathered this was more or less normal with him and Nicole."
"Yes, but...it was different when she was with him. She never let 
him go on like this. It’s been over two weeks! I don't know what to do—  
he won't let me help him."
Gordon, who was doing sit-ups, grunted for attention. "Probably the 
best thing that could have happened," he interjected. "I mean, getting 
involved with his work. Martha ought to know that."
7:00 a.m., October 24. Tape recording (Paul Holliston):
"Administering 500 cc of Methotrexate...a risk, because of its high 
addictive quality. If Methotrexate doesn't arrest the rapid growth, I have 
no choice but to transfer the subject to the University Research Clinic.
I can no longer cope..."
— From F.Tnbryo, by Louis Charbonneau. Based on the screenplay by 
Anita Doohan and Jack W. Thomas.
r* - -
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CHAPTER ONE: INTRODUCTION
PART 1A: Somatic cell hybrids as tools with which to study patterns of
gene expression
The central theme of this dissertation is that there are rules 
which specify the patterns of gene expression which a cell can adopt 
and which govern the changes from one pattern to another, and that one 
can obtain insights into these rules by characterizing somatic cell 
hybrids whose parents differ epigenetically.
This theme is by no means new. Indeed, the earliest experiments 
Harris performed after he and Watkins (Harris and Watkins, 1965) 
introduced Sendai-virus-mediated cell fusion as a means of promoting 
somatic cell hybrid formation were based on such expectations. In 
these studies (reviewed in Harris, 1970), Harris and his collaborators 
showed that when heterokaryons were formed between two cell types, of 
which only one made RNA (or both RNA and DNA) , nucleic acid synthesis 
in the nucleus of the less active parent was induced to match the 
pattern of the other parent. Since these reports, a large literature 
has accumulated based on the characterization of hybrids and hetero­
karyons whose parents differed epigenetically. I intend to draw upon 
this literature only to illustrate the principles discussed below; 
more comprehensive reviews are available (Davis and Adelberg, 1973; 
Davidson, 1974).
The work of Davidson and his collaborators on melanoma x fibro­
blast hybrids not only presented the first detailed study of
1
fry
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2"intertypic" hybrid cells (i.e., hybrids whose parents were of 
different epigenetic types), but also suggested two generalizations 
which later work has, for the most part, supported. An early report 
(Davidson et al., 1966) showed that Syrian hamster melanoma x mouse 
L cell fibroblast hybrids were unpigmented; later work (Davidson,
1972) demonstrated that hybrids formed between the same fibroblast 
line and a melanoma line related to the first one but containing 
twice the chromosome number were often pigmented.
One generalization suggested by these findings is that L cell 
traits predominate in hybrids formed by fusing 1 cells with other 
kinds of cells. Many intertypic fusions have involved L cells or 
other aneuploid fibroblastoid lines with long histories of growth 
in vitro. During the course of such a long and sometimes quixotic 
selection for cells which grew well under artificial conditions (see 
Ham (1974) for a resume of the trials of the L cell line), inadvertant 
selection may also have occurred for cells unusually able to dominate 
intertypic fusions with parents less well adapted to culture. In 
hybrids between these aneuploid fibroblasts and other cell types, 
extinction of the tissue-specific phenotypes of the nonfibroblast 
parent often takes place. A selection of such reports is shown in 
Table 1-1. This table also shows, however, that while the "rule" of 
fibroblast extinction is consistent with the results of many cell 
fusion experiments, much of the data is equally consistent with the 
hypothesis that relative chromosome input ("gene dosage") determines 
hybrid properties. A "pure" test of this "fibroblast extinction" rule 
would require that one fuse a given nonfibroblast line with a number 
of other kinds of cells, including aneuploid fibroblasts, while
ia-,~__
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Other Cell 
Melanoma
Glial
Pituitary
Renal
Neural
Thymic
Friend
NOTES: *
(a)
TABLE 1-1 
REPRESENTATIVE FIBROBLAST HYBRIDS 
Chromosomes
Property Fibro. Other Results
melanin 52 51 extinction
52 91 retention
(some olonei
S-100 protein 53, 75 42 extinction
53 2x 42 ^extinction
GPDH (baseline) 53 42 extinction
53 2x 42 retention
GPDH (induced) 53 42 extinction
53 2x 42 ^extinction
Growth hormone 2x 50 73 extinction
Esterase-2 45 73 ^extinction
various 52 90, 142 retention
(some props
47 92
Thy-1 antigen 50-55 ca. 40 extinction
globin or its 45-70 37-40 extinction
mRNA 22 (a) 37-40 retention
Reference
Davidson et^  al., 1966
Davidson 1972
Benda and Davidson, 1971
Davidson and Benda, 1970
Sonnenschein et al., 1971 
Klebe «rt al^ ., 1970 
Minna et^  al., 1972 
McMorris and Ruddle, 1974 
see Table 1-2 
see Table 1-3
indicates an exception to the "gene dosage hypothesis"
clones which segregate nearly all their human fibroblast chromosomes also make globin mRNA. 
Data on liver cells has been omitted; see Darlington and Ruddle (1975) for a review.
The work on Friend and thymic cells has been synopsized; see text for greater detail.
4controlling for the effects of gene dosage. No such set of experiments 
has been reported.
"Pure" tests of the effects of gene dosage on hybrid character 
have been carried out. In addition to the work of Davidson (1972), 
and the work of Fcugere et al. (1972) on similar melanoma hybrids, 
the studies of Davidson and Benda (1970) on glycerol-3-phosphate 
dehydrogenase in gliai-fibroblast hybrids support the idea that histo­
typic functions extinguished in a set of 1:1 hybrids can nonetheless 
appear in 2:1 nonfibroblast:fibroblast combinations. The data of 
Peterson and Weiss (1972) on albumin expression in hepatoma hybrids 
suggest similar conclusions.
Studies of mtertypic hybrids have demonstrated four other 
phenomena, each of which imposes its own constraints on molecular 
models of gene regulation. The first I want to mention among these 
is the finding of Peterson and Weiss (1972) and of Darlington et al. 
(1974) that a gene which is not expressed in a particular parental cell 
type can be activated when this parent is fused to a cell in which the 
gene is expressed. In the first of these studies, the albumin gene 
of a mouse fibroblast was shown to have been "turned on" by fusion 
with (probably two) rat hepatoma cells. In the other, human albumin 
production was demonstrated in a mouse hepatoma x human leukocyte 
hybrid, in which the hepatoma genome was again at the 2S level. These 
studies do not explain how hepatoma cells maintain their albumin- 
producer status nor how leukocytes and fibroblast maintain their 
nonproducer state, but do prove that subversion of the latter mechanism 
by the former is possible.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5A second phenomenon, that of production, by a hybrid, of molecules 
not produced by either parental cell type, is illustrated by the 
demonstration (McMbrris and Ruddle, 1974) of choline acetyltransferase 
in a mouse neuroblastoma x human fibroblast hybrid, and by the demon­
stration of morphine receptors in neuroblastoma x glioma hybrid cells 
(Klee and Nirenberg, 1974). It is possible in each case that the 
property in question could have been present in a small proportion of 
the neuroblastoma population, and that one of these few cells may have 
been "captured" by hybrid formation; most hybrid clones in the series 
studied do not show the "new" activity.
The third phenomenon I wish to mention is that of dissociation, 
in a hybrid, of differentiated properties which occur together in all 
the cells of one of the parental populations. Minna et al. (1972), 
for example, have examined a series of neuroblastoma x fibroblast 
hybrid lines to see which of the several distinct neuroblastoma marker 
phenotypes were expressed. They found some hybrid clones in which many 
of the neural properties were present, and others in which only a 
subset could be demonstrated. Some of the traits (e.g. action potential 
production) seemed to be present only in hybrids which already possessed 
others (e.g. acetylcholinesterase). Tests of a larger series of hybrids 
might have provided these authors with exceptions to their proposed 
hierarchy of markers. The hierarchy suggested by their results may, 
however, be relevant to the sequence of transitions among epigenetic 
states which occurs in developing neural tissues. An analogous experi­
ment by Szpirer and Szpirer (1975) has shown that mouse hepatoma x 
mouse or rat fibroblast hybrid cells can retain the ability to secrete 
transferrin and C3 (third component of complement, secretion of which
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6is characteristic of the hepatoma cells) but lose the capacity to 
produce albumin and a-fetoprotein. These "dissociation" experiments 
begin to suggest the extent to which particular differentiated pheno­
types are dependent on others with which they are usually associated.
The fourth lesson I wish to abstract from the library of intertypic 
fusions is that chromosome loss can be accompanied by re-expression of 
a differentiated phenotype which had been extinguished in the original 
hybrid cells. The two studies most often quoted in this context are 
the work of Klebe et al. (1970b) on reappearance of a kidney-specific 
esterase in segregating mouse renal adenocarcinoma x human fibroblast 
hybrids, and that of Weiss and Chaplain (1971) on reappearance of 
tyrosine aminotransferase inducibility in rat hepatoma x rat liver 
epithelial cell hybrids. A further example is provided by the finding 
of Kao and Puck (1972) that expression of a group of Chinese hamster 
esterases was dependent on retention of a single human chromosome in 
a set of hamster-human hybrids.
What do these studies tell us about control of gene expression 
in normal, i.e. nonhybrid, cells? Davis and Adelberg (1973) have 
argued convincingly that one cannot draw clean conclusions about 
molecular mechanisms from the sorts of results discussed above. 
Extinction of melanin synthesis in melanoma-fibroblast hybrids, for 
example, might be brought about by dilution of a gene activator 
characteristic of melanoma cells, presence of extra repressor in 
fibroblast cells, or any of numerous other effects, not all of which 
involve transcriptional control of sets of specific genes.
One can, however, draw a few firm conclusions, provided one is 
willing to forswear explanation at the molecular level. The gene dosage
Bk-r--..
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results suggest that whatever molecules mediate epigenetic status are 
not present in very great excess over the concentration required to 
exert their influence. The experiments which demonstrate activation 
of the albumin gene in leukocytes and fibroblasts show a) that cells 
whose ancestors long ago committed themselves away from hepatic dif­
ferentiation have neither lost nor permanently inactivated their liver- 
specific genes; b) that hepatoma cells not only possess the means to 
maintain their own phenotype through mitosis, but also the means to 
activate liver-specific genes in at least some other cell types; and 
c) that these signals can, at least in some cases, work across species 
barriers. The studies of dissociation, in hybrids, of genes ordinarily 
expressed together provide insights into the dependencies of these 
genes on one another, and on the hypothetical loci responsible for 
co-ordination among the markers which we can measure. The work on 
re-appearance, upon segregation, of extinguished tissue-specific markers 
establishes both that these markers can be carried for many generations 
in a latent, alert-but-unexpressed state, and that individual chromo­
somes can mediate the extinction of genes on other chromosomes, even 
across species. This last result is particularly intriguing: if
re-appearance of, for example (Weiss and Chaplain, 1971), TAT inducibil- 
ity truly depends on the loss of a particular chromosome (or set of 
hemologues) from the "extinguisher" parent, this suggests that transfer 
of "extinguisher" status to the corresponding chromosome in the hepatic 
cell's genome does not take place. Clarification of this important 
question will require extension to other sets of hybrids, and, especial­
ly, rigorous karyotypic analysis.
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8One cannot yet predict the phenotype of hybrid cells from a 
knowledge of their parents, although past experience suggests that 
such a prediction must take into account gene dosage, and suggests, 
perhaps, that aneuploid cells long since selected for vigorous growth 
in culture might exert unusual influence over less well-adapted cells. 
Cells of a particular epigenetic type (e.g. skin fibroblasts, or 
erythrocytes, or blastomeres) might well be unusually able to dominate 
intertypic hybrids, or unusually susceptible to influence; but evidence 
bearing on this question is so far scant.
PART IB: Hybridization of thymus cells (and related studies with
thymic leukemias)
Thymus-specific properties have been studied by somatic cell 
hybridization in several laboratories, but mouse thymocytes per se 
were used in only one of the five reports listed in Table 1-2.
Two reports (Hyman and Xelleher, 1975; Liang and Cohen, 1975) 
have shown that when L cells are fused with mouse lymphoid cell lines 
which carry the thymus-marker antigen Thy-1, hybrids can be produced 
in which Thy-1 is no longer detectable. In the study of Liang and 
Cohen (1975), however, the hybrids were shown to carry another thymic 
antigen, Tla. The L cell line used by Hyman and Kelleher contained 
about twice the amount of chromosomal material as did their lymphoma 
parent; Liang and Cohen did not report any karyotypic data.
Namba and Waksman (1975) have shown that when rat thymocytes are 
fused with mouse lymphoblast cells, the hybrids can retain two thymic 
phenotypes: they exhibit a rat thymocyte surface antigen, and produce
Jfcsss-__
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TABLE 1-2 
HYBRIDIZATION OF THYMIC CELLS
Authors
Parkman et al., 1971
Thymic Cell Other Cell
Human thymocyte "Mouse fibroblast"
Parkman and Merler, 1973 Mouse thymocyte clone ID (L cell)
Hyman and Kelleher, 1975 
Liang and Cohen, 1975
Namba and Waksman, 1975
Mouse lymphoma A9 (L cell)
Mouse leukemia LM(TK ) (L cell)
Rat thymocytes Mouse lymphoblast
Result
Cells produced "human Y~gl°bulin 
fragment"
3 clones retain helper activity 
no other thymic properties
All clones Thy-1 negative
Clones Thy-1 negative but Tla 
positive
Thymocyte antigen and MIF 
production
10
migration inhibitory factor. This experiment cannot be considered an 
intertypic fusion, since the mouse lymphoblas to id cells are closely 
related* developmentally, to thymocytes, but it does provide us with 
a control showing that thymus-related phenotypes can survive hybridiza­
tion.
The studies of Parkman and his colleagues are most clearly 
relevant to my work, but are also most open to question. Parkman 
et al. (1971) state, in abstract form, that human thymocyte x mouse 
fibroblast hybrids produce a protein which can be precipitated with 
an antiserum to human y-globulin. "Zero to 60% of colonies" were said 
to have been positive upon initial testing. Acrylamide electrophoretic 
analysis of the immunoprecipitate showed that the protein was neither 
whole y-globulin, light chain, F . fragment, or F fragment. Since
a w  C
thymocytes themselves neither secrete y-globulin nor give rise to cells 
that do, it seems likely that the protein produced by these hybrids, 
although cross-reactive with y-globulin to some extent, may have had 
nothing to do whatever with the lymphoid system. No controls testing 
secretion of this protein by either parent were reported.
Parkman and Merler (1973) later reported, at greater length, the 
results of somatic cell fusions between mouse thymocytes (fractionated 
into classes of different bouyant densities) and cells of clone ID, 
an L cell derivative. One hybrid clone was tested karyotypically, and 
was shown to have 80-95 chromosomes (mouse thymocytes have 40 acro­
centric chromosomes, and clone ID 50-55, of which about 20 are bi-armed). 
Three of the hybrid clones (it is not clear how many were tested, al­
though 27 colonies were isolated) were said to have restored the ability 
of irradiated, bone-marrow-reconstituted mice to produce antibody-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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secreting (plaque-forming) cells when challenged with sheep red blood 
cells. The hybrid cells did not display Thy-1 antigen, did not produce 
a graft-versus-host reaction when injected into suitably incompatible 
mice, did net form spontaneous rosettes with sheep red blood cells, 
and grew attached to plastic surfaces. Taken at face value, these 
results suggest that at least one lymphoid function, helper activity, 
can be retained in L cell-thymocyte hybrids.
The demonstration of helper activity in these hybrids, though 
difficult to explain away, is also quite surprising. For one thing, 
although thymic cells can give rise to T lymphocytes with helper activ­
ity, they cannot themselves contribute helper activity to irradiated 
hosts. It is surprising that these hybrids, while retaining one T 
cell property, seem to have lost the other morphologic, antigenic, 
and functional traits of their lymphoid parent. The finding that 3 
hybrids (out of at most 27 tested) showed helper activity against 
sheep red blood cells raises other questions, because the proportion of 
T cells reactive against this antigen would be expected to be far lower 
than one in nine. None of the hybrids was found to provide helper 
activity against burro red blood cells, or to produce a graft-versus- 
host reaction in allogeneic mice, although these two antigenic stimuli 
would be thought to arouse at least as large a fraction of mouse T cells 
as would sheep erythrocytes. Perhaps sheep-red-cell reactive thymic 
cells are more susceptible to fusion than their burro- or alloantigen- 
responsive neighbors; but it is difficult to see why this should be so.
It is hard to abstract general conclusions from these five studies. 
The three studies in which Thy-1 cells were fused with Thy-1+ partners 
resulted in Thy-1 hybrids. On the other hand, the work of Liang and
M ~ —
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Cohen (1975) on Tla antigens and, given the above reservations, the 
work of Parkman and his co-^workers, suggest that some of the charac­
teristics of thymocytes can be expressed in L cell hybrids. The 
genetic controls on Tla expression are quite complex and not yet well 
understood (see Klein, 1975, pp. 241-251); furthermore, the behavior 
of the Tla antigens in the hybrids of Liang and Cohen (1975) differs 
from that characteristic of these antigens. Further work is clearly 
needed to clarify the fate of thymic phenotypes in thymocyte hybrids.
PART 1C: Hybridization of Friend erythroleukemic cells
Friend (erythro)leukemia cells (FLC) are near-diploid, tumorigenic, 
virus-transformed analogues of proerythroblasts. Many lines of "Friend 
cells" exist, some of independent origin, and some clonally related to 
others; it is not clear to what extent variations among the lines 
represent different stages of erythroid differentiation "trapped" by 
Friend virus transformation. Most Friend cell lines exhibit some 
erythroid properties (e.g. globin mSNA, erythroid antigens, enzymatic 
activities). The most dramatic property of Friend cells is the capacity 
of some lines, when treated with dimethylsulfoxide (DMSO), to progress 
to a normoblast-like stage. This maturation involves diminution in 
size, changes in enzyme activity, and a large increase in the amount 
of both globin mKNA and hemoglobin produced. The properties of Friend 
cells have been recently reviewed (Friend et al., 1974).
Quite a number of cell fusion experiments involving FLC have been 
reported. Orkin et al. (1975) described the properties of hybrids 
between two different FLC lines, one of which was better able than the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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other to undergo DMSO-induced maturation. They found that the hybrids 
contained baseline (i.e. uninduced) levels of globin mKNA. comparable 
to those of the parent cells, but that DMSO-treatment failed to bring 
about much increase in message content. Similar experiments, although 
with slightly different results, have been reported by Paul and Hickey 
(1974), and are not directly relevant to our discussion of intertypic 
fusion. These studies do show, however, that fusion itself need not 
abolish globin mRNA production, at least at the lower, baseline level, 
in FLC.
FLC have also been involved in several intertypic fusions, and 
these are summarized in Table 1-3. Fusion of FLC with 3 different 
clones of L cells, or with hepatoma cells, or with SV40-transformed 
human fibroblasts, all extinguish globin mRNA production, even if the 
hybrid cells are grown in medium supplemented with DMSO. On the other 
hand, fusion between FLC and human marrow cells produces hybrid lines 
in which globin mRNA (or globin itself) can be detected after DMSO 
treatment. One interpretation of these results holds that hybrids in 
which both parents are already committed to erythroid differentiation 
continue to produce globin, but that, for some reason, fusion with 
non-erythroid parents blocks production of globin mRNA. As suggested 
by the data in Table 1-3, however, (and shown in greater detail in the 
original papers), all those intertypic hybrids in which globin can be 
detected have lost the large majority of the chromosomes contributed 
by the non-erythroid parent. All intertypic hybrids in which globin 
expression is extinguished have retained large numbers of chromosomes 
from both parents. It would thus be very useful to examine a hybrid 
between FLCs and a non-erythroid cell whose chromosomes were lost
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TABLE 1-3
INTERTYPIC FRIEND CELL HYBRIDS
Authors Other Cell
Orkin et al., 1975 A9 (L cell)
Deisseroth et al., 1975a B82 (L cell)
VA2 (SV40-transformed 
human fibroblast)
Human marrow (1°) 
Deisseroth et al., 1975b Human marrow (1°)
Chinese hamster fetal 
erythroblasts
Skoultchi et al^ ., 1976 A9
LM(TK_) (L cell) 
Conscience et al, 1976 Hepa-la (hepatoma)
Chromosome Numbers 
FLC Other Hybrids Globin Gene Expression
40 50-60 ? extinguished
38-39 52 69-105 extinguished
39 74 83-94 extinguished
38 46 42 mouse
38 46 42-44 mouse; human
2x 38 46 76-77
38 22 40 mouse; CH in
2x 38 22 71-83
39 54 81-145 extinguished
37 45 57-75 extinguished
39 59 78-141 extinguished
NOTES: The hybrids tested by Deisseroth et al. (1975b) were uncloned populations; some cells 
had received a 2S Friend cell input. Note as well the segregation of human 
chromosomes in the primary human marrow fusions. Globin gene expression was tested 
by assay of either hemoglobin (for Chinese hamster) or globin mRNA.
%;
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early in the evolution of the hybrid clone.
AT 1 of the cells so far shown to extinguish FLC properties have 
not only been non-erythroid, but have been of types whose ancestors 
have passed through developmental branches leading away from the 
erythroid lineage. It would be interesting to examine the properties 
of FLC hybrids whose other parent, while not committed to red cell 
production, had not yet passed through such a branch point: e.g.
hematocytoblast stem cells or one of the precursors of this cell type.
PART ID: Tera to carcinoma as a model system for the mouse embryo
Nature has contrived serious methodological difficulties for the 
mammalian embryologist. Embryos are small, and are hidden away during 
the short period of time in which the developmental "action" takes 
place. Developmental biologists have recently begun to pay attention 
to mouse teratomas and teratocarcinomas as accessible models for 
embryonic systems, in the hopes that from these tumors they could derive 
useful amounts of developmentally-important materials, and could observe 
cells going through interesting transitions. Most research so far has 
been aimed at demonstrating the extent to which the model system 
imitates the natural one, but a few studies have produced insights into 
the surface molecules and viral susceptibilities of teratocarcinoma 
cells (and, by inference, of their natural counterparts) that would 
have been quite difficult to achieve without the tumor model.
The best review of the early work on mouse teratoma is that of 
Stevens (1967a). After his discovery (Stevens and Little, 1954) that 
mice of the inbred strain 129 were unusually susceptible to spontaneous
&■■■ ---__
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testicular teratoma, Stevens spent the next two decades studying the 
origin of these tumors. His influential studies (to be discussed 
below) produced an apparent paradox whose recent resolution has clari­
fied the field considerably (see Damjanov and Solter, 1974, for a 
review).
The first well-studied source of mouse teratomas was the genital 
ridge of the male fetus. In ways that are not yet understood, male 
primordial germ cells (PGCs) can give rise to embryonal carcinoma cells 
(ECCs, the stem cells of teratocarcinomas; see below). This can occur 
either spontaneously, in susceptible strains related to 129, or, in 
certain other strains (e.g. A/He; Stevens, 1970a) when the genital 
ridge containing the germ cell precursors is transplanted from the 
fetus to adult testis. That primordial germ cells gave rise to the 
tumor cells was suggested on circumstantial and morphologic evidence 
by Stevens (1962) and by Pierce and Beals (1964), and confirmed by 
Stevens (1967b), who showed that genital ridges homozygous for Sl^ 
(which, when homozygous, drastically reduces the number of PGCs in 
the genital ridge) were incapable of giving rise to teratomas.
Other studies suggested, however, that teratomas could be produced 
from embryonic cells at stages during which no PGCs were present.
Stevens (1968, 1970b) showed, for example, that when mouse embryos 
from the two-cell to the 6th-day stage were implanted under the testis 
capsule of an adult host, the implanted material produced growths which 
included a variety of tissue types, sometimes including embryonal 
carcinoma cells. Those tumors which contained a good proportion of the 
ECCs were transplantable and were indistinguishable from the transplant­
able teratocarcinomas produced from genital-ridge-derived tumors.
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Transplanted embryos could give rise to teratocarcinomas even though 
they were of strains (C3H) or sexes (female) whose PGCs were incapable 
of producing teratomas spontaneously or through genital ridge trans­
plantation. Histological analysis suggested that the growths were 
derived from the transplanted embryonic cells themselves, rather than 
from PGCs to which the embryonic cells might hypothetically give rise.
Later work by Stevens and Vamum (1974) showed that ovarian 
teratomas were common in another inbred strain, LT, and that the tumors 
in these animals were derived from parthenogenetically-activated 
oocytes. Their careful histologic study showed that activated eggs 
underwent an initially normal development, but that disorganization 
usually began around the time of "blastocyst" formation, after which 
further growth gave rise to typical teratomas, and sometimes terato­
carcinomas .
Teratocarcinomas, then, can be derived from primordial germ cells, 
from pluripotent embryonic cells in 3-6-day-old fetuses, and from 
activated oocytes in females. Damjanov and Solter (1974) have resolved 
these three apparently conflicting results into a convincing picture 
of teratoma development whose central tenet is that teratomas develop 
whenever "mesectodermal precursor cells" (MPCs) are placed into a 
particular kind of "wrong" environment (wrong, that is, for normal 
embryogenesis). They argue that those cells in the egg cylinder which 
ordinarily give rise to the ectodermal and mesodermal tissues of the 
embryo proper can, in a suitable extra-uterine environment, give rise 
to teratomas at very high frequency. In their view, embryonal carcinoma 
cells are (at least early in their history) identical to the mesectoder- 
mal precursor cells except that they are misplaced.
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These precursor cells are obviously present in normal 6-day mouse 
embryos, and can be produced through normal developmental events from 
3-day embryos. Stevens and Varaua (1974) have shown that activated 
LT eggs progress through a series of developmental stages quite 
similar to the changes which take place in a normal embryo, sometimes 
reaching the primitive-streak stage (7.5 days of gestation), but that 
disorganization eventually sets in followed by teratoma formation. 
Therefore these partheaotes, too, contain misplaced mesectodermal 
precursor cells.
The mechanism by which male primordial germ cells give rise to 
teratoma stem cells is less clear. Stevens, in his examinations of 
thousands of early genital-ridge-derived spontaneous and induced 
teratomas, has never sear* stages corresponding to mouse cleavage 
embryos; the first recognizable teratoma cells resemble those of the 
blastocyst inner cell mass (Stevens, 1975). h’ithcut further investi­
gation into the activation process in male PGCs, all one can say is 
that such a transition does occur, and that the mesectodermal precursor 
cells thus produced, in the absence of their "natural" environmental 
signals, give rise to growths which are both disorganized and pro­
gressively growing: i.e., teratomas.
Damjanov and Solter (1974) argue, then, that ECCs (and hence 
teratomas) can be produced in any of these three ways, that the cells 
produced by the three methods are indistinguishable, and, most radically, 
that embryonal carcinoma cells are in no way different from the 
mesectodermal precursor cells from which they come.
This last idea has profound implications, and may well be true.
Most tumors are likely to have been derived from cells "transformed" by
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chemical, physical, or viral agents. These tumor cells may still bear
stigmata of the transforming agent (viral nucleic acid sequences, or,
hypothetically, mutations in genes important for growth control), and
their loss of growth control seems to be irreversible. If ECCs,
however, are normal although misplaced, the factors responsible for 
their tumorigenicity might be very different from those which effect 
most other cell types. ECCs, for example, characteristically retain 
near-diploid chromosome numbers (Gurnet, 1974), whereas most other 
tumors exhibit more severe aneuploidy. It is tempting to view these 
differences in karyotype as effects of underlying differences in the 
ways in which these cells have been rendered tumorigenic.
One important implication of the "normal-but-lost" hypothesis is 
that an ECC placed "back" into a blastocyst, in which it will be 
exposed to the environment appropriate for normal MPCs, will be able 
to regain both growth control and a capacity for normally organized 
and properly timed differentiation. The recent exciting work of 
Brinster (1974), ?rn=»ioannou et al. (1975) and Mintz and Illmensee 
(1975) suggests that ECCs can indeed act just~ai "2 i£■'■zt.o.dermal precursor 
cells if inserted into the blastocyst cavity of normal mouse embryos.
PART IE: In vitro systems for the study of teratocarcinoma
Tumor cells are often studied in tissue culture for the insights 
one can derive into their untransformed analogues, and the preceeding 
discussion suggests that ECCs may be unusually good models for the 
pluripotent mesectodermal cells of the early mouse embryo. Further 
tests of this assumption will be presented in Part IF, below. I want
_
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now to discuss the recent work on in vitro culture of teratocarcinoma- 
derived cells, which has made possible experiments not easily carried 
out on the tumors themselves. Gail Martin’s recent review (Martin,
1975) deals largely with these cultures and is essential reading for 
newcomers to this field.
Figure 1-1 shows the relationships among the different kinds of 
teratocarcinoma-derived cell cultures and the tumor forms from which 
they come. Teratocarcinomas, whether embryo-derived, spontaneous 
(testicular or ovarian), or produced by genital-ridge transplantation, 
are usually maintained by repeated subcutaneous passage in histo- 
compatible mice. Some tumors have also been converted into an unusual 
ascitic form, in which clusters of cells, called "embryoid bodies"
(Stevens, 1959; Pierce and Dixon, 1959), usually containing a central 
core of ECCs surrounded by primary endoderm cells together with varying 
amounts of other cell types, grow free in the peritoneal fluid.
Embryoid bodies are maintained by injection of infected ascitic fluid 
into successive host animals. Embryoid bodies can also produce solid 
growths, with the usual chaotic pattern of embryonal carcinoma 
differentiated tissues, either after implantation on the peritoneal 
wall after intraperitoiteu-L- inoculation, or if a suspension of embryoid 
bodies is injected subcutaneously. ‘ —
Cell cultures can be initiated from either subcutaneous tumors or 
embryoid bodies. These primary cultures contain varying proportions of 
ECCs and differentiated elements, among which primary endoderm is 
usually predominant at first. By the time a primary culture is suf­
ficiently well established to permit subculture, much cell death has occurred, 
possibly involving selection for those cells best adapted to growth
- ______
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Figure 1-1
Derivations of teratocarcinoma cell lines and tumors.
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in vitro. These initial populations can be subcultured repeatedly as 
mixtures composed of ECCs, their newly-differentiated derivatives, 
and the mitotic progeny of those differentiated cells which can still 
divide. The work of Lehman et al. (1974), Gearhart and Mintz (1974), 
Levine e£ al. (1974) and Teresky et al. (1974) has shown that these 
primary and secondary cultures can be used to follow morphological 
and biochemical differentiation of teratocarcinoma cells in culture.
There are a number of ways in which less heterogeneous cell lines 
can be derived from such a mixed culture. The earliest reports of 
teratoma-derived cultures (Finch and Ephrussi, 1967; Rosenthal et al., 
1970; Kahan and Ephrussi, 1970) showed that cloning of cells from 
mixed cultures failed to abolish pluripotency. Cloned cells were able 
to give rise not only to multi-differentiated tumors, but also to 
morphologically heterogeneous culture populations. By subculturing 
from mixed populations in such a way as to favor transfer of the ECCs, 
which attach only loosely to plastic surfaces, one can maintain a 
population which is made up predominantly of pluripotent cells, but in 
which contamination with freshly differentiating cell types repeatedly 
takes place (e.g. Lehman et al., 1974). The SIKR line used by Jami 
et al. (1973) for cell fusion experiments has been shown to be a 
"mixed clone" of this sort (Martin and Evans, 1974).
Teratocarcinoma-derived cell lines in which pluripotent cells are 
no longer present also exist. Many of these seem to consist of fibro- 
blastoid cells not easy to classify further. More interesting 
"monopotent" lines have, however, been produced. Boon jit al. (1974) 
nave derived fvo lines of myoblastoid cells by mechanical isolation 
of beating foci found in a mixed culture. Rheinwald and Green (1975)
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isolated a line of keratinocytes from a mixed culture in two stages: 
first, the mixed population was propagated under conditions which 
favored the growth of epithelial cells, after which the population 
was cloned and a well-differentiated colony picked for further study. 
Mixed cultures can also convert to nonpluripotent cultures simply by 
overgrowth of a differentiated cell type which divides more rapidly 
than the ECCs under the culture conditions used.
Several laboratories have been able to isolate cell lines which 
seem, at least on morphologic grounds, to consist only of embryonal 
carcinoma cells. Jakob et al. (1973) have, for example, isolated 
several of these lines, including a clone called PCC4azal, the 
azaguanine-resistant derivative of clone PCC4 which was used in the 
experiments I have carried out and will discuss below. It is not 
clear why the lines isolated by this group show so little tendency 
to differentiate in logarithmic cultures, since Jakob et al. (1973) 
used the same techniques (cloning and selective subculture) which in 
other hands produced "mixed clones" partially contaminated with 
freshly differentiating cell types. These "pure" ECC lines usually 
retain the ability to produce multi-differentiated tumors, but only 
some of them (Nicolas et al., 1975) are able to differentiate in 
tissue culture, and then only under particular culture conditions. 
PCC4azal, the cell line used in my work, is able to differentiate 
in vivo (Jakob et al., 1973) and after special manipulations in vitro 
(Sherman, 1975a), but appears to consist entirely of ECCs under 
routine culture conditions.
Some ECC lines, after many months of growth in vitro, are found 
tc h=*^ e lost the ability to differentiate in tumors, although they
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resemble the pluripotent ECC lines in feeir other characteristics.
These cell lines are said to he "nullipotent". F9 is the best studied 
line of this type; it was isolated by Granachamp and Ephrussi but 
first mentioned in Bemstine et al. (1973). Recent work (Sherman and 
Miller, in preparation) suggests that F9 cells are able to produce 
parietal yolk sac endoderm, under special growth conditions in vitro, 
and as small, scattered nodules in tumors, but seem to be unable to 
generate other kinds of differentiated cells.
Martin and Evans (1975a, b, c) have recently developed a method 
for isolating pure lines of ECCs which seems likely to supplant the 
other methods used in earlier work. Their procedure involves the 
mechanical removal, from primary or secondary mixed cultures, of 
single embryonal carcinoma cells under the dissecting microscope.
These isolated cells are then cloned on fibroblast monolayers. Martin 
and Evans postulate (1975a) that unselected ECCs require some product 
of the "feeder" fibroblasts. In their view, previous attempts to 
isolate pure ECC lines without the use of feeder layers may have 
failed because of selection for ECCs which continually gave off the 
fibroblastoid derivatives they needed to provide a feeder monolayer.
The success of the Paris group (Jakob et al., 1973) in isolating 
apparently pure ECC lines without feeders may have been due to growth 
conditions which selected for feeder-independent cells; it is not 
clear to what extent this selection may have modified the other 
properties of the pluripotent Parisian lines. Using their single cell 
cloning technique, Martin and Evans have repeatedly obtained, at about 
40% cloning efficiency, lines of ECCs which, when kept on feeder layers, 
show little tendency to produce differentiated offspring. This group
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has also defined conditions (Martin and Evans, 1975a, b, c) under 
which their cell lines can be induced to differentiate. Under some 
regimens, differentiation begins with the formation, in culture, of 
structures much like embryoid bodies. This system seems to furnish an 
excellent in vitro model for two of the earliest determinative 
transitions of the mouse embryo: formation of primary endoderm from
the "embryoblast" cells of the inner cell mass, and the (endoderm- 
induced?) formation of mesodermal derivatives from the remaining MPCs. 
The fidelity with which the differentiating cultures of Martin and 
Evans mimic the early stages of ontogeny reinforces our conviction that 
ECCs are good models of embryonic mesectodermal precursor cells.
We will test this faith further in the next section, devoted to 
the properties of the embryonal carcinoma cell.
PART IF: Properties of embryonal carcinoma cells
My aim in discussing the properties of embryonal carcinoma cells 
is twofold: both to show by what tests these cells can be distinguished
from other kinds (e.g. other parents in a hybridization experiment, or 
other cell types in a mixed culture) and to test further the claim 
that ECCs resemble closely the mesectodermal precursor cells in the 
normal mouse embryo.
Developmental properties.
The important developmental properties of ECCs are two: these
cells are pluripotent, and they are tumorigenic. The pluripotency of
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individual (i.e. cloned) ECCs has been demonstrated in vivo by 
Kleinsmith and Pierce (1964), and in vitro by Finch and Ephrussi 
(1967) and by Rosenthal et al. (1970). ECCs are thought to confer 
transplantability on teratocarcinomas (see Damjanov and Solter, 1974, 
for a discussion), because the capacity of a tumor to survive trans­
plantation seems to be dependent on the presence of morphologically 
recognizable ECCs within it. Although Kleinsmith and Pierce (1964) 
were able to obtain tumors at a low rate (43 tumors from 1790 animals
4
inoculated) by injection of single ECCs, doses of 10 cells/animal are 
usually necessary to produce tumors in most of the injected mice 
(Jakob et al., 1973). Boon et al. (1975) have described the production 
of non-ttimorigenic lines from mutagenized ECC cultures.
MPCs are, of course, also pluripotent. The work of Solter and 
Damjanov (1973) suggests that for a transplanted embryo to give rise 
to a tumor, it is necessary that the MPC-containing half of the egg 
cylinder be included in the graft. Over 50% of transplanted embryos, 
earlier than 8 days of gestation, produce teratomas, of which about 
half contain ECCs and are thus likely to be teratocarcinomas (Stevens, 
1970b; Solter et al., 1975). This high rate of tumor formation suggests 
that at least some of the MPCs in the 2-7-day-old mouse embryo are 
capable of producing transplantable tumors if placed into the right 
environment, even in the absence of carcinogenic treatment.
The discovery of Sobis and Vandeputte (1975) that benign teratomas 
could be produced in rats by displacement of visceral yolk sac endoderm 
to the outside of the uterus (with fetectomy) suggests that MPCs may 
not be the only pluripotent cells in the early post-implantation embryo. 
These rat tumors, however, contain no embryonal carcinoma cells and are
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not tumorigenic; they therefore furnish no evidence against the claim 
that MPCs are the cells which give rise to ECCs in the mouse systems 
under discussion.
Mbrphological properties.
ECCs, however derived, have a characteristic ultrastructure; the 
most recent review is that of Damjanov and Solter (1975) . In tumors 
and in culture, these cells typically exhibit the following features: 
a high ratio of nuclear volume to cytoplasmic volume (compared to most 
well-differentiated cells) ; a prominent, usually single nucleolus, 
centrally located in a nuclexis with little other condensed chromatin; 
and a cytoplasm which contains many free ribosomes but few other 
organelles— mitochondria are present but scarce. The ultrastructure 
of these cells is very similar to that of both primordial germ cells 
in the male (Pierce and Beals, 1964) and mesectodermal precursor cells 
(Damjanov et al., 1971a). Taken together, these structural elements 
combine to produce a phase contrast image (see below) of these cells 
which one can, with a little experience, learn to recognize easily, 
and which is easy to distinguish from that of most other cell lines. 
Cells cultured from the inner cell mass of mouse blastocysts strikingly 
resemble teratocarcinoma-derived ECCs (see figure 1 in Sherman, 1975b, 
for a photographic comparison). Paulin et al. (1976) have described 
ECC-specific patterns of non-histone chromatin protein and soluble 
nuclear protein which may contribute to the unusual nuclear structure 
(not to say developmental properties!) of these cells.
ECCs in culture also exhibit a characteristic growth habit: upon
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subculture, even from a single-cell suspension, they tend to attach in 
clumps, from which the individual cells show little tendency to 
migrate. ECCs in some lines grow as mounds of cells more firmly 
attached to one another than to the substrate. This colonial behavior 
in culture may be a reflection of the tendency of ECCs in tumors to 
form islands of cells surrounded by streams of differentiated cell 
types.
Alkaline phosphatase.
Alkaline phosphatase (APase; E.C. 3.1.3.1), an enzyme demonstrable 
by its hydrolysis of phosphate esters at alkaline pH, but whose role 
in cellular metabolism is not understood, is present in large amounts 
in a number of somatic tissues (bone, intestine, kidney, liver, 
placenta, white blood cells; see Kaplan, 1972, for a useful review). 
Although APase is not present in high levels in most cultured cell 
lines or in most cell types in the early embryo, high specific activi­
ties can be demonstrated in ECCs both in tumors (Damjanov et al.,
1971b) and in culture (Bernstine et_ al., 1973). The demonstration that 
MFCs, alone among the cells of the mouse egg cylinder, have high APase 
levels (Solter eit al., 1973) supports the contention that these cells 
are the normal counterparts of the ECC. APase is also present in high 
specific activity in primordial germ cells (Chiquoine, 1954). Those 
non-pluripotent cell lines derived from teratocarcinoma which have been 
tested for APase, like most differentiated tissues in teratocarcinoma 
tumors, have proven to have little activity (Bernstine et al., 1973). 
Thus, this enzyme serves as a useful marker for the ECC, and its loss, 
a useful though by no means infallible marker for ECC differentiation.
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Response to viruses.
Tollman anH his co-workers have tested the response of cultured 
ECCs to several mammalian viruses, in the hopes that if differences 
could be found between ECCs and other cultured cells in their response 
to virus infection, these differences might provide insights into viral 
metabolism and into the pluripotent state. Swartzendruber and Lehman
(1975) showed that SV40, although able to bring about T-antigen 
synthesis in abortively-infected non-pluripotent mouse cells, was 
unable to produce this antige:: in ECCs. Attempts to transform ECCs with 
SV40 met with failure. Differentiated cells present in mixed cultures, 
however, were able to make both T and V antigens, and were found to be 
susceptible to SV40 transformation. Similar results were obtained 
with another oncogenic DNA virus, polyoma; only the non-pluripotent 
cells were able to produce polyoma T and V antigens, and made infectious
virus as well. (Most mouse cells are permissive for polyoma, br*-
support only abortive infection, with occasional transformation, by 
SV40.) In a second paper, Lehman et al. (1975) demonstrated that ECCs 
were also resistant to infectious SV40 DNA, suggesting that resistance 
is dependent on some event subsequent to viral attachment and unpacking.
Lehman et al. (1975) also showed that an unrelated RNA virus, mengo-
virus, is_ able to replicate in ECCs, but that virus yield is much 
reduced. Jaenisch and Mintz (1974) have shown that exposure of pre­
implantation mouse embryos to SV40 virus can lead to the production of 
adult mice whose cell nuclei contain SV40 nucleic acid sequences, but 
one cannot deduce from their data the cell type or embryonic stage at 
which the viral information was introduced.
.
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Miller et al. (1976; submitted for publication) have shown that 
ECCs are resistant to infection by a mouse parvovirus, MVM; some of 
these results will be presented below.
The resistance of ECCs to a number of viruses which do infect 
non-pluripotent mouse cell lines is relevant here largely as a way to 
distinguish ECCs from other cell types. It seems likely, though, that 
further study of these phenomena will give us insights into viral 
metabolism, and into changes in the intracellular milieu during early 
embryogenesis.
Surface antigens.
Studies of the surface antigens of ECCs have provided, in addition 
to useful markers for these pluripotent cells, new perspectives on the 
genetic control of surface molecules and the role of these molecules 
in ontogeny.
The initial paper in a series of influential collaborative reports 
was that of Artzt et al. (1973). These workers showed that when 129/Sv 
mice were inoculated with cells of a syngeneic "nullipotent" embryonal 
carcinoma cell line, F9, they produced hyperimmune serum cytotoxic for 
F9 cells. A series of direct cytotoxic tests and absorptions showed 
that the sera detected antigens present on all tested ECC lines, but 
not present on any of the many non-pluripotent lines tested, including 
some also derived from 129/Sv teratocarcinomas. These "F9" antigens 
were not found on thymus cells, but were detected on spermatozoa and 
cells in testis suspensions. Immunoperoxidase labelling showed that 
cross-reacting (and possibly identical) antigens were present on
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cleavage-stage mouse embryos.
By using syngeneic cells for immunization, Artzt and her collab­
orators hoped to have manufactured a serum which detected only those 
surface antigens which, though present in early embryos and their 
teratoma-derived analogues, had disappeared from the embryo by the 
time self-tolerance was initiated. (It is not surprising that sperm 
might prove to be an exception, since male germ cells are inaccessible 
to cells of the immune system and can give rise to potent autoanti­
bodies if inoculated around this "blood-testis barrier.") The 
demonstration of antigens common to embryonal carcinoma cells and early 
mouse embryos supported the growing conviction that these cell lines 
were good models for early embryonic cells.
In a second paper, Artzt et al. (1974) showed that spermatozoa 
could absorb anti-F9 cytotoxic activity (as measured with F9 target
cells) to a degree that depended on their genotype. Sperm from an
12
animal which was heterozygous for the mutant allele t (at the complex
T/t locus) were only half as effective in removing anti-F9 cytotoxic
activity as sperm from an animal homozygous for the wild-type allele, 
tl2+ . They concluded that the F9 antigen was probably specified by
the wild-type allele.
The T/t complex comprises a series of interacting loci with 
effects on early embryonic morphogenesis, sperm structure and function, 
and recombination in the chromosome segment stretching at least from 
the T locus to the H-2 complex 13.5 centimorgans distal on chromosome 
17. Three useful reviews (Gluecksohn-Waelsch and Erickson, 1970; 
Bennett, 1S75; and Klein, 1975, pp. 251-274) are available to acquaint 
the novice with the large amount of work which has been done on this
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most mysterious and fascinating of mammalian complex loci. The work 
of Bennett et al. (1972) had suggested that the effects of T/t locus 
mutants on spermatozoa might be mediated by surface molecules. The 
work of Artzt et al. (1974) just discussed showed that the effects of 
these genes on embryonic development might also involve surface 
antigens, and that these molecules could be studied using the terato­
carcinoma model systems. There are several complementation groups 
of recessive-lethal T/t locus mutants; members of a particular group
block embryogenesis at a group-specific stage. The group including
12t (the wild-type allele of which had been associated with F9 antigen)
12 12blocks embryogenesis at a very early stage: homozygous t /t embryos
are unable to proceed from morula to blastocyst. The demonstration 
that F9 antigen was present on late cleavage stage embryos was seen 
by Artzt et al. (1974) as consistent with the idea that this surface 
molecule is necessary for the -transition to blastocyst, and consistent 
with the notion that ECCs are analogous to morula cells.
A third paper (Vitetta et al., 1975) showed that F9 antigen, 
isolated from other surface molecules by immunoprecipitation, shared 
certain biochemical properties with H-2 antigens. Artzt and Jacob 
(1974) showed, around the same time, that F9 cells lacked H-2 antigen, 
at least insofar as could be demonstrated by cytotoxic absorption 
tests. They suggested that the F9 antigen might take the place of 
H-2 on early embryonic cells and ECCs.
The idea had been growing for some time that the association, on 
chromosome 17, of these two most fascinating and mysterious of 
mammalian complex loci had better be explained. (The current basis 
for this suspicion is reviewed in Artzt and Bennett, 1975.) The
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linkage disequilibrium discovered by Hammerberg and Klein (1975)
between the two complexes further suggests that the similarities and
linkage between these sets of loci may be more than just a historical
accident. Biochemical studies of the F9 antigen are still in their
preliminary stages. The smaller of the F9 polypeptides is not
immunologically cross-reactive with mouse g-2-microglobulin, its
counterpart in the H-2 molecule (F. Jacob, personal communication).
Work to compare the amino acid sequence of the F9 and H-2 molecules
is in progress. The identity of the H-2-associated molecule(s) which
interact with products of the T/t locus, and the nature and value of
this interaction are still entirely unknown.
These studies lead to a neat model of surface antigen progression
tl2in developing embryos, in which F9 (+ ) antigen appears before the
morula stage, somehow assists in the morula-to-blastocyst transition,
and is eventually replaced by H-2 molecules. The products of the
other T/t loci might well follow similar schedules at appropriate times
and in appropriate cell types. There are, however, a number of
findings which, while not inconsistent with this model, suggest that
the model may be too simple. For one thing, F9 antigen is present in
mesectodermal precursor cells in mouse embryos at least as late as the
egg cylinder stage (L. Stevens and F. Jacob, personal communication),
as well as on ECCs derived from embryos more mature than blastocysts.
Similarly, H-2 antigen is thought not to appear in the mouse embryo
until 7 days after fertilization (see Billington and Jenkinson, 1975).
It is clear, then, that the postulated replacement of F9 antigen by
tl2H-2 does not occur until long after the stage at which the + gene 
is known to act (the morula-to-blastocyst transition occurs on the 4th
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day after fertilization.) Furthermore, although no one has yet found 
an ECC which lacks F9 antigen, there are several non-pluripotent lines 
which express antigens which can be recognized by aati-F9 serum in 
immunofluorescent assays (my unpublished results and Artzt, personal 
communication.) Furthermore, a similar anti-ECC serum produced by 
Stem et al. (1975) can be absorbed successfully, not only by ECCs, 
but by mouse brain and kidney as well. Although this 129-anti-SIKR 
serum was produced by a protocol similar to that used for anti-F9 
serum, and has a similar spectrum of reactivity (including ECCs, sperm, 
and morulae), it is not clear whether the product is recognizes is the 
"F9" antigen, or is even specified by a gene at the T/t complex. Stem 
et al. (1975) characterized their serum by immunofluorescent assays, 
whereas Artzt and her colleagues use cytotoxic tests; it is not clear 
whether the sets of teratocarcinoma-specific antigens detected by 
these two methods are identical.
Stem e± al. (1975) also looked for the presence of H-2 and Thy-1 
antigens on ECCs and their differentiated progeny. They confirmed the 
result of Artzt and Jacob (1974), mentioned above, that ECCs lack H-2, 
and found that Thy-1 antigen was also undetectable, but that both 
antigens were present in ECC-derived cultures containing large numbers 
of differentiated cells. The earliest of the differentiated cell 
types produced in their system (primary endoderm) was, however, devoid 
of all three antigens: H-2, Thy-1, and the ECC antigen detected by
their anti-SIKR serum.
To sum up: embryonal carcinoma cells seem to lack the H-2 antigens
found on most other cell types, and to possess their own surface 
antigens missing on most cells of later embryonic and adult stages. A
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similar antigenic repertoire is characteristic of mouse morulae, and 
possibly of the mesectodermal precursor cells of the egg cylinder as 
well.
PART 1G: Somatic cell hybridization of teratocarcinomas
Besides the work to be described in this thesis, there have been 
five reports, two of them preliminary, of hybridization between 
cultured teratocarcinomas and other, non-pluripotent cell types.
In the earliest of these, Finch and Ephrussi (1967) fused a line 
of feeder-cloned, 402 AIII embryoid-body-derived cells, shown to be 
able to produce multi-differentiated tumors, with either of two mouse 
fibrosarcomas: LM(TK ) clone ID, or 2472-6-3, a clone of Sanford's
"high cancer" line NCTC 2472. The teratoma-derived parent, called 
clone 8, was said to yield cultures "homogeneous in appearance," but 
the published photograph shows, at the top, cells which seem inter­
mediate in morphology between ECCs (which make up most of the colony 
shown) and the epithelial cell types which often appear in "mixed 
clone" cultures. The fibroblast cells each carried an enzyme deficiency 
preventing growth in the selective HAT medium, but the teratoma line 
carried no selectable marker. Hybrids were produced by mixing the two 
parental cell types without addition of Sendai virus. HAT medium was 
used to kill the fibroblast parent, and colonies of putative hybrids 
were picked for further analysis because they were "distinguishable 
from teratoma cells morphologically and by their higher growth rate." 
Each of the three parents used in these experiments carried at least 
one marker chromosome not found in the other cells, and karyotypic
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hybrid cells. Seven of the hybrid clones were shown to produce tumors 
indistinguishable histologically from the fibrosarcomas formed after 
inoculation of LM(TK~) or 2472-6-3. There was no evidence of either 
embryonal carcinoma cells or differentiated elements (besides fibro­
blasts) in the hybrid tumors.
A very similar study has been reported by Jami et al. (1973).
This group produced and studied hybrids between LM(TK ) clone ID and 
a "mixed done" teratocarcinoma SIKR (Evans, 1972; Martin and Evans, 
1974). Hybrids were produced with the help of Sendai virus, the 
fibroblast parent killed with HAT, and "hybrid colonies...identified 
by their cell morphology which is distinct from SIKR colonies." 
Karyologic analysis showed that the two hybrids isolated had more than 
98% of the "expected" chromosome number for a 1:1 fusion product 
between the two parents. The hybrid cells formed tumors in (129 x 
CS^F^ mice but not in 129 or C3H animals, suggesting that they re­
tained at least some of the histocompatibility genes of both parental 
cells. Isozyme analysis showed that in those instances where the two 
parental cells differed in their proportions of a particular isozymic 
form, the hybrid pattern resembled that of LM(TK ) . In particular, 
"two faster molecular forms of lactate-dehydrogenases were found in 
SIKR" (presumably LDH A^B^ and A^B^; see below) and were absent both 
in clone ID and in the hybrids. The hybrids formed tumors in mice 
which, like those of the fibroblast parent, contained only fibro- 
sarcomatous tissue, devoid of either embryonal carcinoma or any of the 
variety of differentiated cell types found in SIKR tumors. When cell 
lines were initiated from some of the tumors, 4 of the 5 lines derived
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were found to have retained more than 94% of the chromosome number 
characteristic of the inoculated cells; the other tumor had lost 25% 
of the original number.
A report by McBurney (1976), which deals largely with the isolation 
and characterization of several ECC lines, mentions hybridizations 
between two of these lines (0C15 and OC49) and cells of the established, 
subtetraploid, non-tumorigenic mouse fibroblast line, 3T3. A ouabain- 
resistant, TK variant of 3T3 was used, and ouabain employed to select 
against the ECC lines. The 3T3 cells were killed in HAT. All the
hybrid colonies were fibroblastic in morphology and, like their 3T3
parent, contact-inhibited for growth. 0C49 is a near-tetraploid ECC 
line, and contains more chromosomes than the 3T3 line used; 3T3 x 0C49 
hybrids were also fibroblastoid. The hybrid cells were not able to 
form tumors (probably because the 3T3 parents originated in an outbred 
strain of mice) but, when cultured under conditions which promote 
differentiation of the ECC parental cells, gave rise only to fibro­
blastoid cells. McBurney (1976) has also shown that forcing ECCs to
become tetraploid by treatment with cytochalasin B (a drug which permits 
nuclear division but blocks cytokinesis) does not entail a loss of 
pluripotency. Loss of pluripotency in some kinds of teratocarcinoma 
hybrid cells cannot therefore be attributed simply to increased 
chromosome number.
If taken at face value, these results suggest that hybrids between 
a pluripotent cell, such as those which predominate in the terato­
carcinoma cultures used for the fusions, and a differentiated fibroblast 
cell can resemble the non-pluripotent parent. A more detailed criticism 
of this conclusion will be reserved for later.
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Two further (and preliminary) accounts of fusions involving 
teratocarcinoma cell lines have appeared in print. Evans (1975) 
mentions the unpublished thesis research of his student, K. Sit, who 
produced two series of hybrids between SIKR and differentiated parents. 
Two clones of hybrids between SIKR and A9 (a mouse fibroblast closely 
related to LM(TK~)) are said to have produced only fibrosarcomatous 
tumors, in agreement with the results mentioned above. A series of 
8 hybrid clones between SIKR and N86, a mouse neuroblastoma derived 
from the A/J C1300 tumor, are said also to have given rise to fibro­
sarcomatous tu m o rs without evidence of neural tissue. In culture, 
however, these hybrids are said to have had a high content of mono­
amines, which are characteristic of the neuroblastoma parent, but not 
of SIKR. Both series of hybrids were apparently isolated without 
biochemical selection against the SIKR parent; i.e., hybrid colonies 
may have been chosen for study on morphological criteria.
A control series of "self-hybrids" (SIKR x SIKR) was created by 
mixing SIKR cells with Sendai virus and picking "colonies of polyploid 
cells, which could be recognized by their greater size." These 
putative hybrids, with modal chromosome numbers ranging from 71 to 143 
(SIKR mode is 41), were said to produce fibrosarcomas. Evans suggests 
that this surprising result could have come about in one of two ways: 
a) fusion itself might be able to bring about restrictions of the 
hybrids' developmental potential, or b) the fibroblastic cells known to 
contaminate SIKR cultures might be especially susceptible to Sendai- 
mediated fusion.
Another series of teratocarcinoma hybrids has been constructed by 
Bernstine and Ephrussi (1975) and reported in preliminary form. These
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cell i-fnps are the product of fusion between a neuroblastoma line 
(N18TG2, a close relative of the line used by Sit and Evans) and 
H3.6, described only as an "embryonal carcinoma line" with high 
alkaline phosphatase activity. The emphasis in this report is on 
the APase activities in the hybrids. The ECC parent has 18-fold more 
activity than the neuroblastoma parent, but hybrids have from 1.1- 
to 7.6-fold more APase than even the ECC parent. A portion of this 
increase may be due to changes in the response to growth inhibition 
in crowded cultures, in that Bernstine and his co-workers have 
shown that APase can increase at confluence as much as two-fold in 
ECCs. It will be important to learn whether the APase activity in 
the hybrids is like that of the ECC or of the neuroblastoma, since 
related clones of N18 neuroblastoma cells have very high APase 
activity (my unpublished results). Bernstine's preliminary results 
using heat denaturation kinetics suggest that the enzyme in the 
hybrids resembles that of the ECC parent, but more work is needed.
The report of Bernstine and Ephrussi (1975) contains very little 
information about what their hybrid cells look like. One clone, NT3, 
is said to make up a "homogeneous population of fibroblastic cells."
The other two primary clones, NT1 and NT2, are said to exhibit 
morphological heterogeneity in vitro. Subclones of homogeneous type 
have been derived from the more heterogeneous primary clones. Tumors 
derived from NT1 and NT2, and from their subclones, are said to have 
been composed of "one predominant cell type" without "organized 
structure"; "differences between tumors produced by various clones 
have been noted." One cannot tell from these hints whether these 
hybrid cultures and tumors contained ECCs, neural elements, fibroblasts,
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or perhaps other kinds of differentiated cells.
Jami and Loeb (1975) have mentioned unpublished work of Jami and 
Diacumakos to the effect that neuroblastoma x teratoma hybrids re­
semble neuroblastomas. No details are given.
In summary, then: there is as yet no good evidence that terato-
carcinoma-derived hybrid cells can retain pluripotency, although the 
hybrid lines of Bernstine and Ephrussi (1975) may, when reported in 
more detail, retain some of the properties of ECCs. Three sets of 
hybrids between teratocarcinoma lines and mouse fibroblasts have 
resembled their fibroblast parents, although it is difficult in some 
cases to know whether the hybrid actually involved an embryonal 
carcinoma cell. In all these studies, except the case of McBumey's
(1976) 0C49 x 3T3 hybrid, the non-teratoma parent initially contributed 
more chromosomes to the hybrid cells than the teratoma-derived parent, 
so that controls to study the effect of more nearly equal gene dosage 
would be useful.
PART 1H: Production of a-fetoprotein in teratomas
a-fetoprotein (AFP) is a glycoprotein of molecular weight 68,000 
found in high concentrations in amniotic fluid and the serum of third 
trimester mammalian embryos, but which is not present in the sera of 
normal (nongravid) adults. Certain differentiated tumors secrete AFP, 
most notably hepatomas and teratomas, so that detection of this 
substance has become a useful tool in the management of patients with 
these diseases. Abelev (1974) has written a fine review of AFP as a 
marker of embryo-specific differentiation in tumors and in normal
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embryos. A minor controversy has arisen over the question of which 
cells in a teratocarcinoma produce AFP, and it is the purpose of this 
brief section to come down on one side of the controversy.
In the normal embryo, AFP synthesis occurs in the yolk sac 
endodert., and later in the liver (Gitlin and Boesman, 1967; Gitlin 
et al., 1972). Using an immunofluorescent technique, Engelhardt 
et al. (1973) showed convincingly that AFP in mouse teratocarcinomas 
was, not surprisingly, associated almost entirely with endodermal 
derivatives: visceral yolk sac endoderm, and epithelia lining glands
and tubules. Further supportive evidence for the proposition that 
AFP is a product of differentiated endodermal cells is summarized by 
Abelev (1974). Embryonal carcinoma was present in the tumors analyzed 
by Engelhardt et al. (1973), and was found not to be associated with 
AFP-specific fluorescence.
The work of Kahan and Levine (1971), however, had suggested that 
ECCs did produce AFP. Their conclusion was based on two pieces of 
evidence. In the first place, they found a "serum a-l-protein" in 
mice carrying transplantable teratocarcinomas (which contain ECC), 
but not in those with "well-differentiated" primary teratomas (which 
do not). The amount of endoderm in these tumors was not, however, 
given. More significantly, a cloned cell line, T ^  8-10, consisting 
in vitro of a "compact monolayer of undifferentiated epithelial cells", 
and which gave rise to tumors consisting almost entirely of embryonal 
carcinoma with sparse parietal yolk sac, was shown to produce this 
a-1 protein, in vitro and in tumors.
On the whole, the evidence strongly supports the idea that AFP in 
teratocarcinomas originates in endodermal cells. If the protein
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studied by Kahan and Ephrussi was in fact AFP, its production by the 
poorly-differentiating line T17 8-10 is surprising. It is possible 
that this line might not be an ECC line at all, but rather a poorly 
differentiated parietal yolk sac carcinoma (no photographs are shown); 
another possibility is that 8-10 represents a rare variety of ECC 
which has acquired the capacity to produce AFP. The immunohistological 
studies of Engelhardt et al. (1973) show clearly that when embryonal 
carcinoma and visceral yolk sac endoderm are both present in a terato­
carcinoma, only the latter contains detectable AFP. My work (to be 
reported below) is quite consistent with this conclusion.
PART II: Experimental strategy.
The work reported in this dissertation concerns the production 
and characterization of two series of somatic cell hybrids. The PCT 
hybrids are the products of fusion between cells of a pluripotent 
embryonal carcinoma line, PCC4azal, and normal mouse thymocytes. The 
PCF hybrids result from fusions between PCC4azal and a line, FBU, of 
Friend erythroblastic leukemia cells. The purpose of this section is 
to show that these particular hybrid series could help to clarify some 
of the issues discussed above.
Nearly all the intertypic hybrids previously studied have involved 
non-pluripotent, "differentiated" parental lines, whose cells contain 
molecular machinery responsible for the maintenance of a particular 
epigenetic state throughout the cell cycle and through mitosis. The 
eventual phenotype of the hybrid cells, therefore, reflects the con­
flicts and compatibilities between two different sets of stabilizing
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influences. ECCs, though phenotypically stable under some conditions, 
must contain a molecular apparatus, not present in most other cells, 
which permits the ECCs to generate the entire diverse repertoire of 
stable, "mature" epigenetic states.
It is not easy to predict the phenotype of a fusion product, one 
(and only one) of whose parents is able to produce, through normal 
developmental events, cells much like those of the other parental line. 
One might argue that (e.g.) the PCF hybrids ought to resemble the 
differentiated Friend cell parent, since a) the Friend cell is known 
to produce molecules which can impose an erythroid "set" on newly 
synthesized mouse haploid genomes; and b) PCC4azal is known to contain 
a genome in such a state that it can, under conditions that occur in 
normal development, adopt such an erythroid "set". The findings of 
Finch and Ephrussi (1967) and of Jami et al. (1973), which showed that 
teratoma-fibroblast hybrids are fibroblastoid, support this prediction.
On the other hand, the "signals" which Friend cells employ to 
insure the erythroid nature of their mitotic progeny are very likely 
to be distinct from those to which erythroid-bound pluripotent genomes 
are exposed. Pluripotent cells must ordinarily progress through a 
number of stages, starting with the hematocytoblast or its earliest 
precursor, before giving rise to the basophilic erythroblasts which 
the Friend cells (Conscience et al., submitted for publication) mimic. 
Even if the ECC genome were responsive to the molecules which Friend 
cells use to maintain their epigenetic state, it is not certain that 
these influences would survive the "unnatural" early stages of hybrid 
formation. Indeed, the experiments (reviewed in Gurdon, 1974) which 
have shown that pluripotent amphibian oocytes can "reset" the genomes
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of differentiated nuclei inserted into oocyte cytoplasm hint that 
mammalian pluripotent cells, too, might perhaps be able to abrogate 
the epigenetic set of a mature differentiated cell.
As discussed above, several hybrid clones between teratoma-derived 
cells and fibroblasts have been reported; in general, these hybrids 
have resembled their fibroblast parents. PCT and PCF hybrids provide 
especially favorable material to test the generality of the notion 
that hybridization of ECCs destroys their pluripotency. For one thing, 
PCC4azal, FBU, and thymocytes all contain 39-40 chromosomes (and 40- 
43 chromosome arms); thus, considerations of gene dosage ought to play 
less of a role in these hybrids than in hybrids whose fibroblast parent 
contained 50-55 chromosomes (and roughly 55-65 chromosome arms).
Perhaps more significantly, the genomes of PCC4azal and FBU (and, of 
course, normal thymocytes) closely resemble those of normal mouse 
cells. Aneuploid fibroblast cultures continually undergo karyotypic 
modification (Ailerdice et al., 1973; Hashmi et al., 1974), so much 
so that of 11 A9 cells analyzed in the former paper, "no two cells 
had the same chromosome content." ECC cultures, in contrast, are 
remarkably stable (McBurney, 1976), and undergo little change in either 
chromosome number or morphology upon continued passage. Friend cells 
have not been so extensively analyzed, but their stable, near-diploid 
chromosome number and low content of bi-armed chromosomes suggest 
that they, too, resemble normal cells genetically. The rapid karyo­
typic evolution of most aneuploid cultures may well have facilitated 
selection for cells well adapted to growth in vitro, but may in the 
process have produced cells differing from normal ones in ways important 
to epigenetic mechanisms. It is important that developmental lessons
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drawn from studies of hybrids derived from karyotypically unstable 
cells be tested independently.
Finally, embryonal carcinoma cells are interesting in their own 
right. They differ from most other cells not only in that they are 
pluripotent, but in their peculiar surface antigens, their resistance 
to many viruses, and in the ability of some ECCs to produce either 
tumors or normal mice depending on environment. ECC hybrid cells 
ought to give us a chance to test whether any of these properties 
can be dissociated from the others with which it is usually linked.
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CHAPTER TWO: EXPERIMENTAL PROCEDURES
PART 2A: Materials
Unless otherwise stated, all biochemicals used were purchased 
from Sigma Biochemical Co. (St. Louis, Mb.); tissue culture media 
from Grand Island Biological Co. (Grand Island, N.Y.); serum for 
tissue culture from either Grand Island, Flow Laboratories (Rockville, 
Md.), or Microbiological Associates (Bethesda, Md.); radioactive 
chemicals from New England Nuclear (Boston, Ma.); materials for 
electron microscopy from Polysciences (Warrington, Pa.); and plastic 
flasks and dishes for tissue culture from either Falcon (division of 
B.-D. Laboratories, Los Angeles, Ca.) or Corning (Corning, N.Y.).
PART 2B: Cell culture
Unless otherwise indicated, cells were grown in Dulbecco-Vogt 
modified Eagle's medium, "high glucose" formulation, which was purchased 
as a powder and made up in triply glass-distilled water, then filtered 
through Millipore (Bedford, Ma.) filters with final pore size .22 vm, 
and then supplemented with penicillin, streptomycin and kanamycin 
(final concentrations of 50 U/ml, 50 pg/ml, and 100 pg/ml, respectively) 
and 10% fetal calf serum. This medium will be referred to as DVME-FC, 
and serum-free medium as DVME-o. Hybrid cells were selected and grown 
in DVME-FC-HAT, produced by adding hypoxanthine, aminopterin 
(Nutritional Biochemicals, Cleveland, Ohio), and thymidine (final con­
centrations 13 mg/L, 0.19 mg/L, and 3.9 mg/L, respectively), prepared
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as a 10Ox concentrate, to DVME-FC. Hepes buffer (20 mM, pH 7.6-7.8) 
was sometimes added to media in which the hybrid cells were grown.
Embryonal carcinoma cell lines, as well as PCT and PCF hybrid 
lines, were routinely fed on the second day after subculture, and 
split again at a ratio of 1:10 or 1:20 on the third day, using Viokase 
enzyme mixture (Grand Island) in a calcium- and magnesium-free balanced 
salt solution which contained 1 mM Na^EDTA. Other cell lines required 
less frequent subculture. All cells were grown at 37° in a humidified 
atmosphere of 10% CO^ in air.
PART 2C: Production of hybrid cells
PCT hybrids.
A suspension of thymocytes was prepared by teasing the cells from
freshly-dissected thymus glands of two four-week old C3H/HeJ female
mice into DVME-FC. These cells were washed and then resuspended in 
7DVME-o at 2 x 10 /ml and chilled to 4 . Logarithmically-growing
PCC4azal cells were harvested with Viokase solution, washed once in
DVME-FC and once in DVME-o, and resuspended at 10^/ml. The fusion
mixture contained 0.5 ml of each cell suspension and 1 ml of Dulbecco's
phosphate-buffered saline containing 1% bovine serum albumin and 500
hemagglutinating units of (3-propionolactone-inactivated Sendai virus
prepared by the method of Giles and Ruddle (1973) . This mixture was
kept on ice for 20 min. and then swirled at 37° for another 65 min.
The cells were then washed once in DVME-FC and seeded into Falcon 25 
2
cm flasks in DVME-FC-HAT.
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PCC4azal cells are very sensitive to HAT, and did not survive 
the fourth day of incubation; nearly all thymocytes had died by then 
as well. By the ninth day of incubation, each of three flasks was 
found to contain a single healthy colony of attached cells. These 
flasks were fed on day 9, and the medium which was removed from the 
flasks at this (and several later) feedings cultured at 37° in the 
hope of recovering live non-attached cells. No growth was ever seen 
in the cultured fluids, but two of the three attached colonies gave 
rise to proliferating cell lines, which were named PCTA1 and PCTA2.
A second independent fusion was carried out in the same way, 
except that a) only 2.5 x 10^ PCC4azal cells were used; b) the 
thymocyte donor was a 6-week old C3H/HeJ female; and c) the incubation 
at 37° was stopped after only 30 min. Two clones of attached cells 
were derived in this experiment: PCTBla and PCTBlb. Both lines were
derived from the same flask, and may have evolved from the same 
fusion product. A third colony was lost because of poor growth, and 
no non-attached cells could be recovered from the culture fluids 
retained from the early feedings.
PCF hybrids.
Five clones of PCF hybrid cells were produced in two separate 
fusion experiments between PCC4azal and the BrdU-resistant, DMSO- 
inducible Friend erythroblastic leukemia line, FBU. In the first of 
these, 4 x 10^ PCC4azal cells were mixed with 8 x iC^ FBU cells. The 
FBU cells, since their original isolation, had been grown in medium 
containing 30 pg/ml BrdU to select against revertants, and had been
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grown in medium containing 2% DMSO for three days prior to the fusion
experiment. 1 ml of Sendai virus (500 HAU in Dulbecco's PBS with 1Z
bovine serum albumin) was added to the 1 ml of DVME-o in which the
mixture of cells had been resuspended. This mixture was then kept at
4 ° for 10 min, and incubated at 37° for another 20 min. The cells
2
were then seeded into ten 25 cm flasks, and HAT additives were added 
on the following day. Of the several colonies of attached cells which 
appeared within the next two weeks only one, PCFA8, survived for 
further characterization.
A second experiment was carried out in a similar way, except that 
the FBU culture had not been treated with DMSO prior to fusion. Four 
attached colonies of cells, all derived from separate flasks and hence 
presumed to have originated in different fusion events, were isolated 
for characterization: PCFB1, PCFB2, PCFB3, and PCFB5.
Several flasks in these experiments were found to contain 
proliferating populations of non-attached cells. Clones obtained by 
seeding these cells at a concentration of 1 cell/well in Falcon 
microtest plates were found (by isozyme analysis) to be Friend cell 
revertants. It is possible that the non-attached populations 
originally contained hybrid cells which were overgrown by FBD revertants 
and therefore not recovered in the cloning experiments.
PART 2D: Starch gels and chromosome analysis
Starch gel electrophoretic analysis.
Sonicates prepared from cultured cells and from homogenized mouse
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tissues were analyzed for isozyme content essentially by the methods 
of Nichols and Ruddle (1973), except that harvested cells were 
sonicated during the course of sample preparation.
Chromosome analysis.
Rapidly dividing cultures of hybrid and parental cell lines were 
treated with Colemid (Ciba) at concentrations of 0.03-0.06 yg/ml for 
1-4 hours, harvested, swollen in 0.075 M KC1 or in fetal calf serum 
diluted with 3-5 volumes of distilled water, fixed in 3:1 methanol: 
acetic acid, and air-dried onto clean slides. These preparations were 
stained with Giemsa or the fluorochrome 33258 Hoechst, unbroken and 
well-spread metaphase preparations photographed, and chromosome counts 
made either from the prints or from projected negatives.
PCC4azal cells contain two bi-armed chromosomes, of which one 
(marker "P-l") is longer than any of the four bi-armed chromosomes found 
in FBU cells. FBU metaphases, on the other hand, contain two (probably 
homologous) subaetacentrics (F-2) and two (probably non-homologous) 
metacentrics (F-l) which can be distinguished from the remaining 
PCC4azal metacentric (P-2) by staining with 33258 Hoechst. Most mouse 
centromeres fluoresce brightly after Hoechst staining, but the centro­
mere of marker P-2 is much less bright than either of the Friend F-l 
markers. No attempt was made to identify specific chromosomes by 
banding techniques.
PART 2E: Electron microscopy
Monolayers of hybrid cells growing logarithmically in plastic
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tissue culture dishes were prepared for electron microscopy by the 
method of Brinkley and Chang (1973). Glutaraldehyde-fixed, osmium 
post-fixed monolayers were dehydrated and embedded in Epon, sectioned, 
stained with uranyl acetate and lead citrate, and then examined and 
photographed with a Phillips 300 microscope.
PART 2F: Measurement of alkaline phosphatase activity
Alkaline phosphatase activity (E.C. 3.1.3.1; APase) was measured 
in cell sonicates by spectrophotometric quantitation of the hydrolysis 
of p-nitrophenyl phosphate during a 15 min incubation at 37° and 
pH 10.0. The assay is essentially the same as that used by Bernstine 
et al. (1973), and the results are expressed in the same units 
employed by these workers. To confirm that my results could be 
compared directly with the values published by Bernstine's group, I 
measured APase in mouse kidney sonicates. As shown below (see Table 
3-3), the average specific activity I obtained for this tissue (31.5 
limol/hr/mg protein; s.e.m. 3.4) is similar to that obtained by 
Bernstine (28.0; range 21.8-38.0). I assayed each sonicate in 
duplicate on the day of preparation, and the duplicate values were 
averaged to obtain a specific activity for that day's enzyme prepara­
tion. The means shown in Tables 3-3 and 3-4 are thus averages of 
different daily preparations.
PART 2G: Infection of cultured cells by Minute Virus of Mice
The Crawford strain (Crawford, 1966) of the parvovirus MVM
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("Minute Virus of Mice") was obtained from Dr. D. Ward as a suspension 
at 5 x 107 plaque-forming units (PFU) /ml in DVME with 5Z fetal calf 
serum, together with a fluorescein-conjugated rabbit antiserum to MVM 
virions. Details of virus preparation and titration, and antiserum 
production and conjugation are given in Miller, Ward, and Ruddle 
(1976; submitted for publication.)
Cells which were to be tested for the ability to support MVM
infection were seeded in counted numbers onto Lab-Tek 8-chamber slides
4 2(Miles Laboratories) at 1-3 x 10 cells/1 cm chamber. After an over­
night incubation to permit the cells to attach, each monolayer was 
washed once in DVME-o. Virus was added in 0.2 ml of DVME-o, at a 
multiplicity of 20 PFU/plated cell. (Assuming one population doubling 
between subculture and virus addition, this gives an effective 
multiplicity of infection (MDI) of 10.) The virus was removed 1 hr 
later, the appropriate serum-containing medium added (0.3 ml/chamber), 
and incubation continued at 37° for 15-20 hr.
Virus-treated cell cultures were then tested for the presence of 
MVM antigens by an indirect immunofluorescence assay. Slides to be 
tested were washed briefly in PBS at room temperature, fixed in 3:1 
methanol:acetone for 10 min at room temperature, and air-dried. A drop 
of anti-MVM serum, diluted 1:40 with PBS, was placed on the slide and 
covered with a coverslip to distribute the serum evenly over al 1 eight 
chambers. After 30 min at 37°, the slide was washed in three changes 
of PBS, shaken to remove most of the PBS, and covered in the same way 
with a fluorescein-conjugated IgG fraction of goat antibody to rabbit 
IgG (Microbiological Associates), diluted 1:20 in PBS. After a second 
30 min incubation, the slides were washed in three changes of PBS,
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counterstained with 0.005% Evans Blue in PBS with 1% FCS for 30-60 
sec, and rinsed in water. Fluorescent preparations were examined 
and photographed with a Leitz Orthoplan microscope using mercury 
illumination deflected through a Ploemopak vertical fluorescence 
illuminator carrying a filter system designed to provide wide-band 
blue illumination (Leitz Filter System H, which includes two KP490 
excitation filters, a TK510 dichroic prism, and a K510 barrier filter).
Cells which grew in suspension (FBU and concanavalin-stimulated 
mouse splenic lymphoid cells) were infected at an MOI of 10 and a 
cell concentration of 2 x 10^/ml in DVME-FC (FBU) or 10^/ml in RPMI-FC 
(lymphoid cells). After 18-19 hr, the cells were washed in DVME-o, 
resuspended, and a drop of suspension placed on a microscope slide and 
air-dried. These slides were then fixed and stained as described 
above.
PART 2H: Production of tumors from hybrid cells
Cells were harvested in 0.02% Na^EDTA in PBS, washed in DVME-o, 
and injected in counted numbers subcutaneously into young adult mice. 
Some of the tumors were grown in homozygous nu/nu mice (partially 
inbred onto a Balb/c background; Freedman and Shin, 1974), which are 
genetically deficient in their cell-mediated immune response. Other 
tumors were grown in syngeneic animals: PCT cells in (C3H/HeJ x
129/Sv)F^, and PCF in (DBA/2J x 129/Sv)F^ mice. The nude mice were 
raised and inoculated by Dr. S. Shin at Albert Einstein College of 
Medicine, and the syngeneic animals bred and inoculated here at Yale. 
Both kinds of host animals produced similar sorts of tumors. After
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17-45 days, animals with tumors were killed by cervical dislocation, 
and their tumors removed, fixed in aqueous Bouin’s fluid, embedded in 
paraffin, sectioned at 4-5 pm, stained with hematoxylin and eosin, and 
examined with a Leitz Orthoplan microscope.
To learn whether tumor formation had been accompanied by changes 
in chromosome complement, I prepared cultures from 4 of the PCT tumors 
at autopsy, from which chromosome preparations were made 3-4 sub- 
culturings after derivation.
PART 21: a-fetoprotein (AFP) production by hybrid tumors
Blood was drawn from some of the tumor-bearing animals just prior 
to sacrifice. Serum from these mice was tested, after storage at -50°, 
for the presence of mouse AFP by the discontinuous counterimmuno- 
electrophoretic technique of Wallis and Melnick (1971, 1972). Micro­
scope slides were coated with 1% agarose (Seakem) gel containing 12 mM 
barbital buffer (pH 8.6), and wells punched into the agarose were 
loaded with about 5 yl of the antigen to be tested, diluted 1:4 with 
buffer. Rabbit antiserum to mouse AFP was pipetted into the cathodal 
series of wells. Slides were then subjected to electrophoresis at 200 
volts/8 cm slide, for 30 min at room temperature. Reservoir and bridge 
buffers were at five-fold higher buffer concentration. The antiserum 
used (the gift of Dr. B. Ledford) was produced in a rabbit injected 
with electrophoretically purified AFP isolated from a cultured mouse 
hepatoma line, Hepa. The serum was absorbed with mouse albumin prior 
to use. I have tested the specificity of this serum in several ways. 
First, it gives a single precipitin line in a standard immunoelectro-
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phoretic assay when tested against either mouse amniotic fluid, Hepa 
culture fluid, or serum from a mouse carrying an OTT6050 ascitic 
teratocarcinoma; the antiserum, however, produced no precipitin line 
when tested against adult mouse serum. Second, when this antiserum is 
compared with a second, independent anti-AFP serum, produced by Dr. E. 
Zimmerman by immunization of a goat with mouse amniotic fluid-derived 
AFP, a line of identity is produced in double diffusion analysis, 
using mouse amniotic fluid as antigen. I used the rabbit antiserum 
to mouse AFP at a dilution of 1:4 in 12 mM barbital buffer.
After discontinuous counterimmunoelectrophoresis, the agarose- 
covered slides were washed for 2-4 days in several changes of saline, 
washed once overnight in distilled water, dried, stained with 0.025% 
Coomassie Blue B in a mixture of methanol, water, and acetic acid 
(45:45:10), and destained in the same solvent mixture.
PART 2J: Production and titration of anti-Thy-l alloantiserum
An alloantiserum to detect the presence of Thy-1.2 antigen was
prepared by a method based on that of Reif and Allen (1964a) . Strains
v
AKR/J and C3H/HeJ are both H-2 , but differ at the Thy-1 locus, so 
that immunization between these strains produces a serum uncontaminated 
by anti-H-2 antibody. Such sera may, however, contain antibodies 
directed against molecules unrelated to Thy-1 antigen.
AKR/J female mice (7 weeks old when first inoculated) were injected 
intraperitoneally, once a week, with a suspension of C3H/HeJ female 
thymocytes, at a concentration of 10^ cells/0.2 ml inoculum. The 
recipient mice were bled from the tail 6 and 10 days after the fifth
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Injection. Antiserum was heat-inactivated (to remove complement) at 
54® for 30 min, and stored in aliquots below -50°.
This antiserum was titred in a one-step cytotoxic test against 
C3H/HeJ thymus target cells. Equal volumes of diluted antiserum, 
diluted rabbit serum (as complement source) , and cells (2 x 10^/ml) 
were mixed and incubated at 37° for 45 min, after which trypan blue 
was used to assess cell death. The serum, in the presence of comple­
ment, killed more than 95Z of the target cells at high concentrations, 
and killed 53Z at a dilution of 1:1280. DVME-o with 4% heat-inactivated 
fetal calf serum was used as diluent.
nhcu titred in the two-step cytotoxic test employed (see below) 
for absorption analyses on ECC and hybrid cells, this serum killed more 
than 50% of the target C3H thymocytes at a dilution of 1:2000.
PART 2K: Cytotoxic absorption tests for cell surface antigens
Hybrid cells and appropriate controls were tested for the presence 
of H-2 and Thy-1 cell surface antigens by a modification of a standard 
method (e.g. Artzt and Jacob, 1974) involving absorption of cytotoxic 
antibody from well-defined sera. In the usual test, the antiserum is 
first titred for cytotoxic activity against target lymphoid cells by 
mixing counted numbers of target cells with a series of dilutions of 
the antiserum. After a period of sensitization, during which antibody 
binds to the cells, complement (Cf) is added. After a further 45 min 
incubation at 37°, the fraction of the target cell population still 
viable is measured, e.g. by counting the proportion still able to ex­
clude a dye, trypan blue, which only enters dead cells.
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After this titration, cells of interest can be tested for antigen 
by an absorption assay, as follows. A fresh aliquot of the antiserum 
is diluted to the lowest concentration found to kill 60-90% of the 
target cells. The diluted serum is then mixed with the cells in whose 
surface antigens one is interested. After an incubation, the cells are 
spun out, and the absorbed serum tested for residual cytotoxicity 
against target cells. What one learns from the absorption test is 
whether the tested cells carry antigens which cross-react with those 
both a) present on the target cell, and b) recognized by the antiserum 
used.
In a series of preliminary experiments not to be discussed here in 
detail, I observed that when this standard cytotoxic test was used, 
embryonal carcinoma cells and their hybrids often seemed to absorb 
cytotoxic antibody even from sera from which no absorption ought to 
have been observed. F9 cells, for example, absorbed cytotoxic anti- 
H-2 antibody, even though they did not carry the specificities detected 
by the serum used. Several attempts to circumvent this non-specific 
absorption— e.g., by pretreating the F9 cells with bovine serum 
albumin, or pre-absorbing the anti-H-2 serum with F9 before use— all 
failed to prevent absorption, by F9 cells, of cytotoxic activity in 
excess of the small amount absorbed by negative control cells. In 
addition, I found that F9-absorbed sera were often more cytotoxic if 
diluted 1:2 than if used without dilution.
This last observation suggested that absorption of sera with ECCs 
might be rendering the sera anti-complementary. Were this the case, 
one would expect that F9-absorbed sera would always be less cytotoxic 
than control—absorbed aliquots, not because the F9 cells had removed
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antibody, but rather because F9-absorbed serum, when mixed with C', in 
some way inhibited the C'-dependent cytotoxic reactions. The increase 
in cytotoxic activity after a 1:2 dilution could be due to such an 
inhibitory influence if it acted with different stoichiometry than 
did antibody. Interference from anti-complementary activity could be 
overcome by modifying the cytotoxic test to prevent contact between C' 
and the absorbed serum. When such a modified test was carried out 
(see below), I began to obtain consistent results with acceptably low 
absorption in cases where ECCs were used as negative controls.
The cytotoxic test used to produce the results reported below was 
therefore carried out as follows:
1. Cells to be tested for surface antigen content were freed 
from monolayer cultures by two washes in PBS, followed by a 5 min 
incubation in PBS with 0.02Z Na^EDTA. Cells were shaken free, poured 
into an equal volume of cold diluent (DVME with 4% heat-inactivated 
fetal calf serum), sedimented at 4° (800 rpm, 4 min in an IEC model 
PR-6 with a #253 head), and resuspended in diluent. The cells were 
then packed by centrifugation at 1500 rpm for 5 min.
Lymphoid cells to be tested were teased from the appropriate 
organs into diluent, washed twice, and pelleted at 1500 rpm for 5 min.
Cultured suspension cells were prepared in the same way as 
lymphoid cells, except that they were washed three times. In an experi­
ment not shown, PBS-EDTA treatment of suspension cells was shown not 
to diminish detectably their ability to absorb anti-H-2 antibody.
2. Absorption. An appropriate alloantiserum (see below) was 
diluted to a level just sufficient to kill 60-90Z of target cells, and 
stored frozen in aliquots containing enough serum for one day's use.
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50 pi of diluted serum were pipetted into each of a set of 400 pi 
tubes. The pellet of cells prepared in step #1 above was carefully 
freed of surface diluent, and 25 pi of packed cells were transferred 
to the tubes of serum. The cells were dispersed in the serum by 
gentle agitation, and the tubes incubated at 4° for 40 min, after 
which the cells were pelleted in a Beckman micro fuge.
3. Target cells were prepared by teasing the mesenteric lymph 
node (for H-2 assays) or thymus gland (for Thy-1 assays) into diluent. 
Cells were triturated, washed three times in the cold, counted, and 
suspended at 2 x 10^/ml.
4. 20 pi each of diluent, absorbed antiserum, and target cell
suspension were pipetted into 3 ml conical tubes kept at 4°. Each 
absorbed serum sample was divided into two 20 pi portions and thus 
assayed in duplicate. Each series of tubes included two in which 
diluent was substituted for antiserum ("C1 only control") and two in 
which unabsorbed serum was used. Each batch of diluted antiserum was 
tested to verify that cell death in its presence was in fact C'- 
dependent, but this control was not repeated for each day's work.
These tubes were incubated for 40 min in an ice-water bath.
5. After this sensitization, target cells were washed in 2.5 ml 
of diluent and sedimented (10 min, 800 rpm, 4°). Supernatant was 
removed except for an estimated 25 pi covering the pellet. 50 pi of 
rabbit C', absorbed with A9 cells as described below, and diluted to 
a concentration found to be optimal for each batch (ranging from 1:8 
to 1:12), was then added. The cells were resuspended, warmed quickly 
to 37°, and incubated for 45 min at this temperature.
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6. The tubes were then placed in an ice-water bath, and 50 yl 
of .20Z trypan blue in saline was added before an aliquot was examined 
in a heaocytoaeter. (The trypan blue was stored as a .25Z solution in 
water, and mixed with .25 vols of 4.2Z NaCl just before use.) 1QQ 
cells were counted from each tube.
Calculations.
The fraction of cells killed by a particular aliquot of absorbed 
serum is not itself the most useful measure of the ability of the
absorbing cells to remove antibody, since this value is subject to
several influences which suffer day-to-day variations: e.g. the initial 
viability of the target cell population, susceptibility of a given 
mouse's cells to C', minor diluting errors, incubator temperature, 
etc. For this reason, the counted fraction of viable cells was con­
verted into a measure of "residual cytotoxicity" as follows:
1. Cytotoxic index (Cl) was calculated as
T - C 
100 - C
where T is the fraction killed in the serum being tested and
C is the fraction killed in the C'-only control.
This figure expresses killing as a fraction of the live cells not 
killed by C' alone, and compensates for variations in C' activity, 
initial cell viability, and susceptibility to C 1. The Cl for the C'- 
only control is by definition zero.
2. Residual cytotoxicity (RC) is calculated for each absorbed
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serum as
100 x Cl (T)
Cl (U)
where Cl (T) is the cytotoxic index for the absorbed serum being 
tested and Cl (D) is the cytotoxic index for the unabsorbed control.
The RC for the unabsorbed control is thus by definition 100.
Complement.
Complement (C’) for use in cytotoxic tests was prepared by the 
method of Boyse e£ al. (1970). Rabbit serum (either drawn from 
selected rabbits by cardiac puncture or purchased frozen from Grand 
Island Biological Co.) was made 10 mM in Na^EDTA by addition from a 
lOx stock. The serum was then absorbed with A9 cells (washed several 
times in DVME-o) at 4° for 30 min with occasional agitation. Different 
batches of C' were absorbed with packed volumes of A9 cells ranging 
from 10-25Z of the C' volume. During the absorption, naturally- 
occurring rabbit antibody to mouse cell surface antigens is removed, 
while the EDTA prevents consumption of C'. After the absorption, the 
C' was separated by centrifugation at 4° for 5 min at 2000 g, and 
enough 20 mM CaC^ added to compensate for the EDTA. Absorbed C' was 
stored in 0.5 ml aliquots at -90°; once thawed, an aliquot was never 
refrozen for later use.
Specificity.
It is important to recognize the limitations of specificity in this
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technique as used with currently available antisera, and the tricks 
which are used to improve specificity. If, for example, one produces 
an "anti-H-2^" serum by injecting A9 cells (C3H/HeJ; H-2^) into Balb/c 
mice (H-2^), and then uses this serum to kill A9 cells in a cytotoxic 
test, one will be able to detect H-2 antigens on the surfaces of 
cells used for absorption. Such a system is, however, not specific 
for H-2 antigens, since the serum may well contain antibodies to other 
surface molecules (viral antigens, minor H antigens, etc.) present 
both on the immunizing and target cells. The principal precaution 
used to increase the specificity of cytotoxic tests is to use co- 
isogenic mice throughout. To test for H-2 , for example, one might 
produce an antiserum in C57BL/10 ("BIO") mice by injection of lymphoid 
cells from the co-isogenic strain B10.BR, which differs genetically 
from its parental strain BIO only by the introduction of genes closely 
linked to the H-2 complex introduced from the C57BR strain. Such an 
antiserum, if tested on B10.BR target cells, will only detect surface 
antigens coded for, or controlled by, genes closely linked to the 
major histocompatibility complex (MHC) and the H-2 loci.
It is worth noting that such a test system is still not entirely 
specific for any single antigen. Among the complicating factors are 
the following:
1. H-2 haplotypes contain two loci, called K and D, which produce
highly immunogenic cell surface antigens. An antiserum can often be 
made specific for one or the other of these loci by the use of appro­
priate strains, one of which has undergone intra-MHC recombination.
Both of the H-2 antisera used in this study (see Table 2-1) are of this 
type, and are directed against H-2K molecules.
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TABLE 2-1
SYSTEMS FOR CYTOTOXIC TESTS OF H-2 ANTIGEN EXPRESSION
Antigen Serum Immunogen Responder Target H-2 Specificities Detected
H-2 D33 BIO.A (5R) 
KbDd
(B10.D2 x A)F
KdDd xKV
C57BL/10
KbDb
33, 53, 54 (H-2K )
H-2 D3b C3H
kV
(C3H-H-2 x 129)Fx B10.BR
KdDk x KbcDbc KkDk
11, 23, 25, 52 (H-2K )
Details of the immunization procedures are given in Snell (1968). These sera were obtained 
through Dr. John Ray of the Collaborative Research office of the National Institute 
of Allergy and Infectious Disease, NIH. The underlining indicates the molecule that 
the antiserum was designed to detect; as noted in the text, these antisera may contain 
antibodies directed against other molecules as well.
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2. Cross-reactions, due to the so-called "public specificities", 
may occur between different individual H-2 antigens. Reference to a 
list of H-2 specificities (Klein, 1975, p. 126) can help one to decide 
whether a particular antiserus-target cell combination can detect a 
public specificity likely to be present on the cell whose surface 
composition one wishes to examine.
3. Recent work has shown that the MHC includes genes which code 
for surface molecules other than H-2K and H-2D; these new antigens are 
called la antigens (for review, see Klein, 1975, pp. 450-54. For 
recent information on strain distributions, see G&'tze, 1976.) In 
addition, it is likely that the MHC contains loci coding for surface 
antigens still to be recognized. Anti-H-2 sera, even those produced 
through immunization of co-isogenic strains, may be "contaminated" 
with antibodies to the products of these loci. It is also possible 
that some of the MHC gene products act to control the expression of 
surface antigens coded for in other areas of the genome.
Table 2-1 summarizes the cytotoxic systems used in this disserta- 
b ktion to test for H-2K and H-2K antigens. For the reasons just stated, 
a cautious interpretation of results obtained using such sera would be 
that although most of the absorption of cytotoxic activity brought 
about by a test cell is likely to represent classical H-2K determinants 
on the cell surface, one cannot rule out absorption due to the products 
of loci which are linked to H-2 but are not yet well-defined.
PART 2L: Measurement of acetylcholinesterase activity
Acetylcholinesterase (E.C. 3.1.1.7; AChE), an enzyme present at
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high specific activity in erythrocytes, is also found in Friend erythro- 
leukemia cells (Conscience et al., submitted for publication), but not 
in embryonal carcinoma cells (see below). PCF hybrid clones were 
tested for AChE activity essentially by the method of Lewis and 
Eldefrawi (1974). Harvested cells were sonicated in 50 niM phosphate 
buffer, (pH 7.4, 1Z in NP40 detergent); the sonicate was clarified by 
centrifugation (30,000 g, 30 min, 4°) and divided into aliquots which 
were frozen until use. The reaction was carried out in a total volume 
of 150 pi, and is based on the measurement of radioactive acetate re­
leased from acetylcholine substrate during a 20 min incubation at room 
temperature. Acetate is separated from unhydrolyzed substrate by thin 
layer chromatography on strips cut from Gelman Type SA ITLC plates, 
using 80Z ethanol as solvent, which are tested for radioactivity. Each 
set of assays included duplicate determinations for each aliquot, as 
well as blanks in which 1Z NP40 in buffer was substituted for the 
enzyme solution. The percent hydrolysis given by the blank was sub­
tracted from each result before further calculation; this correction 
averaged 6-8Z hydrolysis, and was in most cases roughly 10-fold greater 
than the hydrolysis attributable to enzyme activity in ECC and PCF 
sonicates (blank-corrected), though of course much lower than the 
hydrolysis produced by FBU sonicates.
PART 2M: Other methods
Friend cells and cells harvested from monolayer culture were 
stained for hemoglobin by the benzidine method of Orkin et al. (1975). 
Two drops of benzidine solution were added to a single drop of cell
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suspension in a well of a Falcon micro test plate.
Protein was measured by the method of Lowry et al. (1951), using 
bovine serum albumin as a standard, during the course of enzyme assays.
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CHAPTER THREE: RESULTS
PART 3A: Demonstration that PCT and PCF cells are in fact hybrids
PCT cells.
As described in Part 2C, above, two monolayer cell lines, PCTA1 
and PCTA2, were derived from a Sendai-mediated fusion between PCC4azal 
and C3H/HeJ mouse thymus cells. A second, similar fusion produced two 
other cell lines, PCTBla and PCTBlb, which appeared as separate colonies 
in the same flask, and might therefore have been derived from a single 
fusion product. Attempts to isolate lines of non-attached cells from 
the fusion mixtures were unsuccessful.
Because these cell lines grew in a medium (DVME-FC-HAT) in which 
neither parent was able to divide, they were presumed to be hybrids.
Two experiments were carried out to test this presumption.
Sonicates of each of the four cell lines, together with appropriate 
controls, were checked by starch gel electrophoresis for their pattern 
of glucose phosphate isomerase (GPI; E.C. 3.5.1.9) isozymes. Figure 
3-1 shows that each of the four cell lines contains both the GPI-A 
marker characteristic of the PCC4azal parent and the GPI-B enzyme found 
in the C3H/HeJ thymocyte parent, as well as an AB heterodimer found 
only in cells carrying alleles for both forms. A cell containing equal 
numbers of active A and B alleles would be expected to produce the three 
isozymes in ratios of 1:2:1 (AA:AB:BB); the relative densities of the 
three bands in the PCT cell lines, as in the (C3H/HeJ x 129/J)F^ hybrid 
mouse thymus control, conform moderately well to this expectation. This
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Figure 3-1
Glucose phosphate isomerase isozymes in PCT hybrids and controls.
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result shows that each PCT line contains cells with some genetic input 
from each parental cell, and suggests that each hybrid line arose from 
the fusion of one thymocyte with one ECC.
Chromosome analysis supported this idea. Figure 3-2a shows a 
metaphase preparation of a typical PCT hybrid cell, and figure 3-3 
presents histograms of chromosome number for each of the PCT lines.
Table 3-1 shows the summary statistics derived from the chromosome 
counts of these lines and of the PCC4azal parent. The expected 
values shown in this table are based on the assumptions that the 
thymus parent contained 40 acrocentric chromosomes, that the PCC4azal 
parent contained the modal number of its population (39) including both 
of the bi-armed marker chromosomes, and that no chromosome loss occurred 
after fusion from a 1:1 hybrid. The PCT hybrid populations contained 
92-95% (means) of the expected chromosome number, and 80-90% of the 
hybrid metaphases showed both of the PCC4azal marker chromosomes.
Although it is conceivable that extensive chromosome loss has taken 
place, accompanied by reduplication of the remaining chromosomes, it 
seems far more likely that each hybrid cell contains most of the 
chromosomes introduced by each parent.
The chromosome analysis, together with the GPI isozyme pattern, 
shows that these cell lines are products of fusions between single 
thymus cells and single PCC4azal cells. Each parent probably contributed 
about the same amount of genetic material to the initial hybrid cell.
The results of serological analyses to be presented below show 
that the PCT lines also contain a second marker from the thymus parent, 
H-2^, and that at least three of the lines carry the H-2tc allele found 
in the 129/Sv parent from which PCC4azal was derived.
 Jfewaa*-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 3-2
Metaphase preparations of hybrid cells and parents.
a) PCTA1. Giemsa-stained. 71 acrocentrics; 1 P-l; 1 P-2.
b) PCC4azal. Hoechst-stained. 37 acrocentrics; 1 P-l; 1 P-2.
c) FBU. Hoechst-stained. 34 acrocentrics; 2 F-l; 2 F-2.
d) PCFB2 (passage 8). Hoechst-stained. 96 acrocentrics; 1 P-l;
2 P-2; 2 F-l; 2 F-2.
Code: P-l
P-2 
F-l 
F-2
single triangle, 
double triangles, 
single arrow, 
double arrows.
Note that photographs shown are not to the same scale. Note the presence 
of two doses of PCC4azal marker P-2 in the PCFB2 metaphase shown.
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Figure 3-3
Distribution of chromosome numbers in PCT hybrid populations.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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TABLE 3 -1
CHROMOSOME CONSTITUTION OF PCT HYBRID CELLS
Cell Line Mean # S.D. N % With 2 Bi-armed
PCTA1
PCTA2
PCTBla
PCTBlb
75
73 
75
74
2.8
3.7
3.2
3.3
39
20
21
23
97
85
86 
87
PCC4azal
Thymocytes
Expected
38
(40)
79
1.7 32 100
(0 )
100
Values given are the mean numbers of chromosomes found in N 
metaphases examined for each cell line, except that the values given 
for thymocytes were assumed. S.D. gives the standard deviation of the 
distribution. Expected values (for a 1:1 hybrid) are based on the 
assumptions given in the text. Values for mean and S.D. for PCC4azal 
were computed after excluding near-tetraploid cells which are, however, 
included in the histogram (figure 3-6). Note that the strong modal 
value for the PCC4azal population, 39, is slightly above the mean 
chromosome number.
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PCF cells.
As described in Part 2C above, five monolayer cell lines were 
derived from two fusion experiments between PCC4azal and the Friend 
ppII line FBU. A single clone, PCFA8 , survived the first experiment; 
the second produced four independent clones: PCFB1, PCFB2, PCFB3, and
PCFB5. Attempts to isolate lines of non-attached hybrid cells were 
not successful. The PCF cells grew well in DVME-FC-HAT, and were 
tested further to see if they were truly hybrid.
The mouse strains, 129/Sv and DBA/2J, from which PCC4azal and FBU 
were, respectively, derived differ genetically with respect to the 
isozymes phosphoglucomutase (PGM: E.C. 2.7.5.1) and isocitrate dehydro­
genase (IDH; E.C. 1.1.1.42). Each putative PCF hybrid clone was tested 
for PGM and IDH isozymes within 6-10 passages of its original isolation. 
Figure 3-4 shows that each of the PCF clones (together with a clone, 
PCFB4, which was subsequently lost) has both the two bands of PGM-1A 
activity characteristic of 129/Sv (PCC4azal) cells, and the two bands 
of PGK-1E activity of the DBA/2J (FBU) parent. Figure 3-5 shows 
similar results for IDH. PCC4azal has a slower-migrating isozyme, 
IDH-1A, while the faster IDH-1B form is characteristic of FBU cells.
Each hybrid clone has both these isozymes, together with an AB hetero- 
dimer. It is worth noting that the A and B forms seem to be of equal 
intensity in PCFB3 and PCFB5 sonicates, but that sonicates of PCFA8 , 
PCFB1, and PCFB2 have more of the PCC4azal form, and more dimer, than 
they have B isozyme. This suggestion of a greater ECC contribution to 
the latter three hybrid clones is confirmed by the chromosome data 
to be discussed next.
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Figure 3-4
Phosphoglucomutase isozymes in PCF hybrids and controls.
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Figure 3-5
Isocitrate dehydrogenase isozymes in PCF hybrids and controls.
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Figure 3-6 shows the distributions of chromosome numbers in meta­
phase spreads prepared from these cell lines. The results shown by 
open bars (for PCFA8 and PCFB2) were obtained 21-26 passages after the 
data indicated by the closed bars. Table 3-2 gives summary statistics 
condensed from the histograms and data on the presence, in the hybrid 
cells, of marker chromosomes characteristic of the two parental popula­
tions. The "expected" values are based on the assumptions mentioned 
above in connection with the PCT chromosome data, except that expected 
values for 2:1 (PCC4azal:FBU) hybrids are also given. Figure 3-2 
(b,c,d) presents a Hoechst-stained metaphase spread of a typical PCF 
hybrid cell, together with similar preparations from each parental line.
The IDH data illustrated in figure 3-5 and discussed above suggests 
that PCFB3 and PCFB5 were each the product of fusion between equal 
numbers (presumably one) of PCC4azal and FBU cells. The chromosome 
numbers are consistent with the idea that these clones originated in 
1:1 fusions, followed by loss of about 1 0 % of the initial chromosome 
complement. On the basis of length, centromere position, and intensity 
of centromere staining with the fluorochrome Hoechst 33258, it is 
possible to distinguish from one another four kinds of bi-armed 
chromosomes in PCC4azal and FBU cells. Two of these (P-l and P-2) are 
present in PCC4azal, and most of the PCFB3 and PCFB5 metaphases had a 
single copy of each of these markers. F-l and F-2, similarly, are FBU 
markers, each represented in two examples in FBU cells. (It is not 
clear whether these represent two sets of similar but distinct chromo­
somes.) Most PCFB5 metaphases had two examples of each Friend cell 
marker, and most PCFB3 cells had two examples of F-2 and one of F-l.
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Figure 3-6
Distribution of chromosome numbers and markers in PCF hybrids and 
parental populations.
Note that two separate chromosome preparations were performed on
clones PCFA8 and PCFB2. The distributions indicated by the 
open bars were obtained 21-26 subculturings after those 
indicated by the closed bars.
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TABLE 3-2
CHROMOSOME CONSTITUTION OF PCF HYBRID CELLS
Cell Line Mean # S.D. N Markers (>30% of Cells)
P-l P-2 F-l F-2
PCC4azal 38 1.7 32 1 1 0 0
FBU 39 1.9 29 0 0 2 2
Expected (1:1) 78 ------- — 1 1 2 2
PCFB3 70 5.8 38 1 1 1 2
PCFB5 73 4.0 33 1 1 , 0 2 2
Expected (2:1) 117 ------- — 2 2 2 2
PCFA8 94 9.7 16 1,2 2 1,2 1,2
PCFB1 107 10.3 34 2 1 2 , 1 2 , 1
PCFB2 97 1 2 . 1 18 2 , 1 2 2 , 1 2
For each cell line, N cells were counted to give a mean total 
chromosome number/cell, and a standard deviation (S.D.) was computed 
from the distribution. Four "marker" chromosomes could be distinguished 
on the bases of length, centromere position, and affinity for Hoechst 
33258 dye. The numbers given for marker chromosomes are modal, and include 
all modes in which at least 30% of the cells of a given population joined. 
When two modes are given, the one listed first was the more common.
Assumptions used to compute expected values are as given in 
the text. Note particularly that the strong mode of the PCC4azal 
population, 39, is slightly higher than the mean number of PCC4azal 
chromosomes.
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The data are consistent with the idea that these hybrids resulted from 
a 1 : 1 fusion.
Similar considerations support the hypothesis that PCFA8 , PCFB1, 
and PCFB2 are the products of fusions between one Friend cell and two 
PCC4azal cells, although chromosome loss seems to have been more exten­
sive than in the 1:1 hybrids. Note particularly the frequent presence, 
in metaphases of these three lines, of two copies of the PCC4azal bi­
armed markers. The histograms for lines PCFA8 and PCFB2 shown in 
figure 3-6 support the notion that these cells can lose chromosomes 
during their period in culture.
In summary, and given the caveats discussed above with reference 
to the PCT lines, the chromosome and isozyme analysis of the PCF clones 
demonstrates that the cells are indeed hybrid, that PCFB3 and PCFB5 
retain most of the chromosomes contributed by each genome, and that the 
other three PCF clones, after formation from the fusion of two PCC4azal 
cells with a single FBU cell, progressively lose up to 25% or more of 
their original chromosome complement.
PART 3B: Morphology of PCT and PCF cells in culture
PCT cells.
Figure 3-7a shows what PCT cells look like when grown logarithmical­
ly as monolayer cultures on plastic substrates. Figures 3-7b and 3-7c 
show, for comparison, the two parental cell types. PCT cells, like 
their ECC parent, grow as clusters of loosely attached cells. The ratio 
of nuclear volume to cytoplasmic volume is high compared to that of many
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Figure 3-7
Morphology of cultured PCT and parental cells.
a) PCTBla. Phase contrast; 330x.
b) PCC4azal. Phase contrast; 330x.
c) Mouse thymocytes. Phase contrast; 330x.
d) PCTA1. Transmission electron micrograph; 4900x.
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other cultured cell types. By phase contrast, the nucleus typically 
contains a single prominent phase-dense nucleolus within an otherwise 
phase-lucent nucleoplasm; there is very little chromatin emargination. 
Nuclei with two prominent nucleoli are more common in PCT cultures than 
in the PCC4azal parental line, probably because the former cells are 
near-tetraploid. Although no one of these traits is diagnostic of ECCs, 
together they make up a gestalt which is sufficiently compelling to have 
induced experts in teratoma cultivation (F. Jacob, personal communica­
tion) into mistaking cultured PCT cells for their PCC4azal parent.
The electron micrograph shown in figure 3-7d demonstrates that PCT 
cells closely resemble PCC4azal cells at ultrastructural resolution as 
well. The numerous free ribosomes, paucity of endoplasmic reticulum, 
lack of distinctive organellar apparatus, and predominance of euchroma- 
tin in the nucleus have all been described by other workers (see 
Damjanov and Solter, 1975) as characteristic of ECCs. Stobo et al. 
(1972) present several electron micrographs of murine thymocytes. Like 
ECCs, thymocytes have a high nucleus/cytoplasm ratio, few cytoplasmic 
organelles, and numerous free ribosomes. Thymocyte nuclei, however, 
unlike the nuclei of PCC4azal and PCT cells, contain large amounts of 
condensed chromatin, distributed throughout the nucleus but especially 
plentiful at the nuclear periphery. Paulin et al. (1976) have found 
biochemical correlates of the unusual nuclear morphology of ECCs; it 
would be interesting to test the composition of the nuclear proteins of 
PCT hybrid cells with this in mind. Thymus cells, of course, also 
differ from PCT and PCC4azal cells in that they do not form clumps and 
do not attach to the surface of tissue culture flasks.
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PCF cells.
Figure 3-8 shows what cultured PCF cells look like, and shows, for 
comparison, phase contrast micrographs of the two parental cell types. 
Figure 3-8d is an electron micrograph of a section through a PCFB3 
culture. Although PCF cells usually have more than one nucleolus 
(perhaps because they have more than one diploid equivalent of genome), 
the morphological similarities to PCT hybrid cells and PCC4azal cells 
are apparent. Some of the PCF cells in the cluster shown in figure 3-8a 
have formed a mound rising above the plastic surface into the medium; 
this growth habit is typical of many ECC cell lines, though not of 
PCC4azal itself. The electron micrograph shows that the PCF cells 
resemble ECCs at ultrastructural resolution as well. (The section shown 
happens not to have passed through a nucleolus.)
Sato et al. (1971) have discussed the ultrastructure of Friend 
cells as part of their study of DMSO-induced changes in these lines.
They found that Friend cells, prior to any exposure to DMSO, and like 
PCC4azal and PCF cells, have high ratios of nuclear volume to cytoplas­
mic volume, and numerous free ribosomes. Friend cell cytoplasm also 
contains occasional lipid vacuoles and intracisternal A-type particles. 
The most obvious ultrastructural difference between Friend cells, on 
the one hand, and ECC and PCF cells on the other, is in nuclear morphol­
ogy. Friend cells have large amounts of emarginated heterochromatin, 
and two nucleoli which, in stained preparations, are much less prominent 
than the single ECC nucleolus. Cultured Friend cells also neither clump 
nor attach to plastic surfaces (although one can select for weakly- 
attached Friend cell populations.)
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Figure 3-8
Morphology of cultured PCF and parental cells.
a) PCFB2. Phase contrast; 330x.
b) PCC4azal. Phase contrast; 330x.
c) FBU. Phase contrast; 330x.
d) PCFB3. Transmission electron micrograph; 6000x.
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In view of the fact that other teratocarcinoma hybrids, including 
hybrids with neuroblastoma cells (Evans, 1975), are said to have re­
sembled fibroblasts, it is worth noting that PCT and PCF hybrids 
clearly do not resemble cultured fibroblasts morphologically.
The tissue type which predominates in poorly differentiated areas 
of PCT- and PCF-derived tumors also closely resembles embryonal carci­
noma tissue (see Part 3E, below.)
In summary, then, PCT and PCF cells resemble their ECC parent 
ultrastructurally, in their phase contrast appearance, and in their 
growth habit.
PART 3C: Alkaline phosphatase levels in PCT and PCF cells
Table 3-3 shows the results of a series of APase determinations 
carried out on third-day (near-confluent) cultures of PCT hybrid cells, 
together with measurements made at the same time on control materials.
As explained above, these experiments were prompted by the demonstration 
of Bernstine et al. (1973) that cultured ECCs, like their counterparts 
in teratocarcinoma tumors, had high levels of this enzyme. To see if 
my results could profitably be compared with the values reported by 
i-M r group, I included mouse kidney homogenates in many of the assays, 
and found that the value I obtained (31.5 ymol/hr/mg protein; s.e.m. 
3.44) was similar to that obtained by Bernstine's group (28.0; range 
21.8-38.0).
The specific activities of APase in two ECC lines, F9 and PCC4azal, 
are presented in Table 3-3 as well. These levels are near the lower end 
of the range reported to be characteristic of ECC lines, but 10-20 times
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TABLE 3-3
ALKALINE PHOSPHATASE IN PCT HYBRIDS AND CONTROLS
Cell line Specific Activity S.E.M.
PCTA1 3.91 0.51 8
PCTA2 3.61 0.50 8
PCTBla 2.09 0.38 8
PCTBlb 2.50 0.38 8
PCC4azal 4.04 0.56 6
F9 5.09 0.53 7
TSD4 0.21 0.04 4
Thymocytes 0.53 0.18 7
Kidney 31.48 3.44 9
Specific activities are given in yMoles p-nitrophenyl phosphate 
hydrolyzed/hr at 37°/mg protein. The values given are 
the means and standard errors of the means of N separate 
daily preparations.
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M ghpr than the activities found in most other cultured cell lines 
(Bernstine et al., 1973). Data for one non-pluripotent line, TSD4, a 
fibroblast ceil line derived from OTT6050 embryoid bodies, is presented 
in Table 3-3. Mouse thymus cells also contain less APase than ECCs.
All four PCT hybrid lines have significantly more APase than either 
their thymocyte parents or TSD4; one of the four has significantly less 
enzyme than the PCC4azal parents, and the other three have slightly but 
not significantly less than their ECC parent (statistical analysis not 
shown). Histochemical experiments showed that nearly all cells in 
logarithmic PCC4azal and PCT cultures had detectable amounts of enzyme, 
and that the activity was concentrated, as is the case for embryonal 
carcinoma cells in tumors (Damjanov and Solter, 1975), at the inter­
cellular boundaries.
Table 3-4 shows comparable data for the five PCF hybrid clones. 
These results were obtained several months after the ones shown in 
Table 3-3, and it is worth noting that the specific activity of the 
PCC4azal subline used as a control for the PCF experiments had somewhat 
more APase activity than the closely related line I had used earlier.
The divergence in related sublines suggests that small differences in 
APase activity between ECC lines, even if statistically significant, 
may not be biologically important. All five PCF clones have as much 
or slightly more APase activity than their PCC4azal parent, even though 
FBD has no detectable APase.
In summary: PCT and PCF hybrid cells have high levels of alkaline
phosphatase, an enzyme characteristic of embryonal carcinoma cells. The 
levels in the hybrids are comparable to those of PCC4azal, but much 
higher than those of the non-pluripotent parent in each case, and higher
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TABLE 3-4
ALKALINE PHOSPHATASE IN PCF HYBRIDS AND CONTROLS
Cell Line Specific Activity S.E.M. N
PCFA8 9.94 1.37 5
PCFB1 7.22 1.52 5
PCFB2 9.54 0.78 5
PCFB3 10.15 1.41 5
PCFB5 10.88 0.88 5
PCC4azal 7.32 1.58 5
FBU <0.1 ---  3
Specific activities are given in pMoles p-nitrophenyl
phosphate hydrolyzed/hr at 37°/mg protein. The values
given are the means and standard errors of the means of
N separate daily preparations.
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than the levels typical of most other cultured cell types.
PART 3D: PCT and PCF cells are resistant to infection by the mouse
parvovirus, MVM
As discussed above, Swartzendruber and Lehman (1975) and Lehman 
et al. (1975) have shown that embryonal carcinoma cells are resistant 
to infection by SV40 and polyoma, two small DNA oncogenic viruses.
These viruses were, however, able to infect differentiated (non- 
pluripotent) teratocarcinoma-derived cells. Stimulated by their find­
ings, I investigated the interactions of a mouse parvovirus, MVM, with 
ECC cultures and other cell lines. In a collaborative study (Miller, 
Ward, and Ruddle, submitted for publication), I established that re­
sistance to MVM infection was characteristic of ECCs in culture, but 
that teratoma-derived fibroblasts, like most non-teratoma lines 
examined, were susceptible to MVM infection. The immunofluorescent 
assay for MVM antigens is illustrated in figure 3-9, which shows that 
PCC4azal, unlike A9 (an established mouse fibroblast line), TDla (a 
teratocarcinoma-derived fibroblast), and FBU, fails to produce detect­
able nuclear antigen upon exposure to MVM virus. Table 3-5 summarizes 
the results of a similar set of experiments in which the effect of 
increased viral MOI was quantitated.
PCT and PCF hybrid cells, like their PCC4azal parent, are resistant 
to MVM infection. Each PCT clone was tested in three separate experi­
ments, and each PCF clone tested 2-5 times. Representative areas of 
infected and stained cell cultures are shown in figures 3-9e,f. No 
immunofluorescent nuclei were seen in any of the experiments, except
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Figure 3-9
Immunofluorescent detection of MVM intranuclear antigen in PCT 
and PCF hybrid cells, and in controls.
a) A9 mouse fibroblast; positive control.
b) TDla; teratocarcinoma-derived fibroblast.
c) PCC4azal; embryonal carcinoma parent.
d) FBU; Friend erythroleukemia cell parent.
e) PCTA1.
f) PCFB2.
Note that all the cells have a dim cytoplasmic fluorescence (dull 
red under the microscope) due to the Evans Blue counterstain. 
Some A9, TDla, and FBU cells have, in addition, a bright 
nuclear fluorescence (green in the original) due to the presence 
of MVM viral antigen. PCT and PCF cells, like their PCC4azal 
parent, do not contain MVM antigen after exposure to virus.
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TABLE 3-5
MVM INFECTION: PROPORTION OF STAINED CELLS
Cell Line MOI 2. S.D. N
A9 10 .22 .019 501
A9 2 0 0 .35 .027 307
PCC4azal 10 .00033 .00033 =3075
PCC4azal 2 0 0 .0018 .0005 =7380
TSD4 10 .37 .026 341
FBU 10 .033 .006 947
MOI gives the number of PFU of virus added per cell, assuming that 
one population doubling has occurred between subculture and addition of 
virus. Column p gives the ratio of immunofluorescent cells to total cells 
examined, and S.D. gives the standard deviation of this number. N is the 
actual number of cells counted for A9, FBU, and TSD4, and the approximate 
number scanned for PCC4azal, estimated by counting the cell number in the 
first five fields examined, and multiplying by the number of fields looked 
at in all.
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that two of the PCT clones, in one of three experiments conducted, had 
areas with several positive nuclei. Each experiment involved the 
examination of several thousand cells from each hybrid clone.
MVM is known to require S-phase cells for its proliferation
(Tattersall, 1972). There was no indication that my conditions of
infection interfered with the cell cycle in the resistant cultures, but,
in order to eliminate this consideration entirely, I tested infected
cultures autoradiographically for the ability to incorporate thymidine
into cell nuclei. Virus-treated hybrid cells, like PCC4azal cells, were
3
able to accumulate intranuclear H-thymidine but did not accumulate 
viral antigen; A9 cultures tested in parallel had many nuclei which 
were both radioactive and fluorescent.
As shown above, FBU cells are susceptible to MVM infection, and 
this susceptibility is extinguished in the PCF hybrids. It is not 
meaningful to test mouse thymocytes in the same way, as a control for 
the PCT hybrids, since thymus cells do not divide in culture, while MVM 
infects only proliferating cells. Concanavalin-A-stimulated splenic 
lymphoid cells, most of which are derived from thymus-processed 
lymphocytes (Stobo et al., 1972), were also tested, and were found not 
to accumulate MVM antigen. This is not surprising, considering that 
MVM, like other parvoviruses, seems not to interfere with mitotic cell 
populations in adult animals (for review, see Toolan, 1972).
In summary: PCT and PCF hybrids resemble ECCs in that all three
cell types, unlike most permanent mouse cell lines, are resistant to 
infection by the parvovirus MVM. Whatever factors make Friend cells 
susceptible to MVM infection are extinguished after hybridization with 
the ECC line, PCC4azal.
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PART 3E: PCT and PCF cells give rise to multidifferentiated tumors,
some of which produce a-fetoprotein.
Each clone of PCT and PCF hybrid cells was tested to see whether 
it could produce tumors after subcutaneous inoculation into mice. Even 
after inoculation of as many as 1 0 7 cells into genetically appropriate 
animals, "take" incidence of some hybrid lines remained low, as is 
shown by the data presented in Table 3-6. A detailed study of those 
factors (age and sex of host, size of inoculum, syngeneic vs. nude host, 
etc.) which might influence the fraction of successful inoculations was 
not carried out.
Tumors were, however, produced from all of the four PCT clones 
and from four of the five PCF clones. Some tumors were produced in 
mice homozygous for the gene "nude," which impairs cell-mediated immune 
responses (Freedman and Shin, 1974); others were produced in syngeneic 
F^ hybrid mice. Of the three PCT tumors tested, all three were shown 
to be transplantable: pieces of tumor tissue removed at autopsy and
inserted subcutaneously into F^ mice gave rise to progressively growing 
tumors.
Cell lines were derived from four of the PCT tumors and tested for 
chromosome and isozyme content to see to what extent the tumor cells 
resembled the originally inoculated population. As shown in Table 3-7, 
all four tumor-derived cell lines retained GPI heterodimer, and thus 
are known to contain at least one chromosome from each of the parental 
cell strains. Three of the four tumor lines had chromosome numbers 
indistinguishable from those of the original populations; the other 
had lost about 7 of its original 75 chromosomes. By the end of their
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TABLE 3-6
INCIDENCE OF TUMOR FORMATION BY PCT AND PCF HYBRID CELLS
Cell line Incidence
PCTA1 
PCTA2 
PCTBla 
PCTBlb 
Total PCT
4/4
4/6
3/4
4/9
15/23 (65%)
PCFA8 '/7'
PCFB1 0/4
PCFB2 1/4
PCFB3 2/4
PCFB5 2/4
Total PCF 8/23 (35%)
Tumor incidence is expressed as number of tumors/number of 
animals inoculated. Three tumors produced by transplantation of 
PCTBlb primary tumors have been omitted from the data in this 
table.
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TABLE 3-7
CHROMOSOME NUMBER AND ISOZYME ANALYSES OF CELL LINES 
DERIVED FROM PCT TUMORS
Tumor Cell Line Mean # S.D. N Orig. # GPI I
Tll-2 PCTA2 72 4.6 21 73 +
Tll-3 PCTA2 72 2.6 19 73 +
T4-3 PCTBla 68 3.0 19 75 +
943 PCTBlb 75 2.3 21 74 +
Cultured cells derived from tumors of the indicated hybrid cell lines 
were used to prepare metaphase spreads 3-4 subculturings after initiation 
of each culture. N metaphases were counted to yield a mean chromosome 
number and a standard deviation (S.D.) for each distribution. The mean 
chromosome number characteristic of the inoculated cell line is also 
listed. The final column indicates the GPI heterodimer was demonstrated 
in each tumor-derived population.
Analogous data for PCF-derived tumors is not available.
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second passage la vitro, these tumor-derived cell lines contained only 
cells which resembled ECCs (and hence the Inoculated PCT cells) 
morphologically.
All the tumors were fixed, sectioned, and stained with hematoxylin 
and eosin for histological evaluation. Table 3-8 presents the results 
of the histological analysis of the PCT tumors. Illustrative histolog­
ical sections are presented in figures 3-10, 3-11, and 3-12, as well as 
in 3-14c,d. Because of the lower "take" incidence of the PCF cell lines 
(see Table 3-6), fewer PCF-derived tumors were available for analysis; 
Table 3-9 summarizes the data from the eight PCF tumors obtained.
Figures 3-13 and 3-14a,b show sections of PCF tumors.
All of the tumors contained embryonal carcinoma, examples of which 
are shown in figures 3-10a and 3-13a. The presence of embryonal carci­
noma in hybrid-derived tumors is consistent with the other data sug­
gesting that these cell lines resemble their ECC parent, PCC4azal. The 
three PCFA8 tumors were composed entirely of embryonal carcinoma, and 
several of the PCT tumors were largely embryonal carcinoma, in which 
could be found small islands of differentiated tissue.
All the PCT tumors, and each of the five PCFB2, PCFB3, and PCFB5 
tumors contained at least some differentiated tissue. In general, 
tumors with the greatest variety of tissue types also contained the 
largest proportion of non-ECCs. Several of the tumors were largely 
necrotic at the time of autopsy, but contained nodules of cartilage; 
these tumors are left otherwise undiagnosed (empty spaces) in Table 
3-8.
Some tissue types were seen frequently. All the tumors (except, 
of course, those from PCFA8) had at least some primitive neural tissue,
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TABLE 3-8
DIFFERENTIATED TISSUES FOUND IN PCT HYBRID TUMORS
PCTA1 PCTA2 PCTBla PCTBlb
CO
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H
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H
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H
C”» tr* H  E-i
Embryonal carcinoma + + + + + + + + + + + + + + + +
Ectodermal cords - + + + + + + + + + + t - - + +
Primitive neural tissue + + + + + + + + + + + JL + + +  +
Mature neural tissue - + + + + + + + - + + - + + + +
Stratified squamous
epithelium - - - - - + + — — — — — — — +  +
Mesenchyme - + + - - - - - - - - - - - +  -
Muscle - + + - - - - - - - - - - - +  -
Cartilage - + - + + - - + + + - - - - - - + +
Endodermal epithelium + + + - + + - + - - - - + + +  +
Ciliated epithelium - + - - - + - - - - - - - - +  +
Glandular structures - + - - - - - - - - - - - - +  -
Parietal yolk sac - + - - - - - - - - - - - - ---
Polyploid giant cells - + - - - - - - - — - - - - +  -
a-fetoprotein + — — +  +
A (+) sign indicates that the tissue was found in the tumor indicated; 
a (-) sign indicates absence. An empty space in the a-fetoprotein row 
shows that no test was carried out for the animal in question. Tumors 
954 and 973 were largely necrotic, but nodules of cartilage were apparent 
in each. All tumors are primary, except that T4-3, T4-4, and T4-5 were 
derived from transplantation of T4-2; T4-5 is a second generation transplant. 
T-series tumors ere produced in syngeneic (C3H/HeJ x 129/Sv)F^ mice, and 
the others in nu/nu animals.
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Figure 3-10
Hematoxylin- and eosin-stained sections of PCT hybrid tumors.
a) Typical poorly differentiated area, with an ectodermal cord
at center left. Tumor 876; xl60.
b) Well differentiated area. Note ciliated epithelium (ce),
cartilage (ca), as well as embryonal carcinoma (ec).
Tumor T8-1; xl80.
c) Well differentiated area. Note glandular tissue (gl) and
several endodermal vesicles (for example, en). Neural 
tubule at left of center. Tumor T8-1; xl80.
d) Ectodermal cords. Tumor T4-4; xl80.
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Figure 3-11
Hematoxylin- and eosin-stained sections of PCT hybrid tumors.
a) Endodermal vesicle. Tumor 943; xl45.
b) Ciliated epithelium. Tumor T8-1; x440.
c) Parietal yolk sac. Note Reichert's membrane indicated by
arrows. Tumor T8-1; x440.
d) Glandular tissue. Tumor T8-1; xl80.
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Figure 3-12
Hematoxylin- and eosin-stained sections of PCI hybrid tumors.
a) Cartilage. Tumor T4-1; xl80.
b) Immature muscle. Tumor T4-1; x440.
c) Neural tubules. Tumor 943; xl80.
d) Giant cells. Tumor T8-1; x440.
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TABLE 3-9
DIFFERENTIATED TISSUES FOUND IN PCF HYBRID TUMORS
PCFA8 PCFB2 PCFB3 PCFB5
CM CO t—1 i—( ■ r-H <N ■ ■ i—1 CM1 I"sT 1
o  o  r~-» . t r  i
i
<3-
i i
CO CO
1 1 
CO COc_j1~J fcH t—)
H
tH  1---(
Eh  H
CH CH
Tissue
Embryonal carcinoma + + + + + + + +
Ectodermal cords ----------- + + + ~  +
Primitive neural tissue ---------------- + + + - +
Mature neural tissue ----- + + — - -
Cartilage ----- + + + + +
Muscle ----- + + + ~ +
Endodermal epithelium -- -- - + + + +
Ciliated epithelium - - - + + + + ~
a-fetoprotein -- -- - --- +
A (+) sign indicates that the tissue was present in the
sign denotes absence. No test for a-fetoprotein was performed on animal 
T3-2. Tumors 1042 and 1043 were produced in nu/nu mice, and all others 
in syngeneic (DBA/2J x 129/Sv)F^ animals.
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Figure 3-13
Hematoxylin- and eosin-stained sections of PCF hybrid tumors.
a) Embryonal carcinoma cells. T7-1; xl75.
b) Cavities lined with ectodermal epithelium, with embryonal
carcinoma at lower left and primitive neural tissue in 
the central band. T3-1; xl75.
c) Cavities lined with ciliated endodermal epithelium.
T13-1; x430.
d) Primitive neural tissue with organized neural tubules.
T13-1; x430.
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Figure 3-14
Hematoxylin- and eosin-stained sections of PCT and PCF hybrid tumors.
a) Rhabdomyosarcoma tissue in a PCF tumor. T13-1; xl75.
b) PCF tumor with cartilage nodule, rhabdomyosarcoma tissue
around it, and primitive neural tissue at right, above 
center. T13-1; xl75.
c) Stratified squamous epithelium, with transition to ciliated
epithelium, and with a vesicle of ciliated epithelium 
above; from a PCT tumor. T10-1; x430.
d) Mature neural tissue, from a PCT tumor. HO-1; xl75.
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which in some cases made up nearly all the bulk of the tumor. Organiza­
tion of this tissue into neural tubules (figures 3-12c, 3-13d) was 
common. Mature neural tissue (figure 3-14d)» cartilage nodules 
(figures 3-10b, 3-12a, 3-14b), cavities lined with endodermal epithelium 
(figure 3-lla), and cords of ectodermal epithelium (figures 3-10d,
3-13b) were present in many of the tumors. Some tissue types, including 
ciliated and secretory endodermal epithelium (figures 3-10b, 3-llb, 
3-13c), stratified squamous epithelium (figure 3-14c), parietal yolk 
sac with Reichert's membrane (figure 3-llc), and glandular structures 
(figure 3-lld), were present only in the well-differentiated tumors.
Bone and pigmented tissue were not observed; these tissues are common 
in primary teratomas, but considerably less so in transplantable 
teratocarcinomas which have been passaged for many generations (L. C, 
Stevens, personal communication).
Scoring for mesodermal derivatives in these tumors is difficult. 
Cartilage is easy to recognize, and cannot be confused with host tissue. 
Confident diagnosis of muscle and connective tissue is, however, tricky 
in poorly differentiated tumors when they are enmeshed in host connec­
tive tissue and subcutaneous muscle. As a consequence, my scores for 
these two sorts of tissue are most likely underestimates. I accepted 
mesenchyme and muscle tissue as tumor-derived only when I found them 
isolated from the strands of penetrating host tissue; most such areas 
were close to areas of cartilage. Some areas of muscle tissue (figure 
3-12b) resembled immature cardiac muscle, and are thus unlikely to 
have been host-derived.
PCF (though not PCT) tumors contained large amounts of the tissue 
shown in figure 3-14a. These large, pleomorphic, multinucleated cells
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were usually found near cartilage nodules, and resemble (L. C. Stevens, 
personal communication) cells found in rare teratocarcinomas undergoing 
transition into rhabdomyosarcomas. All four PCF tumors diagnosed in 
Table 3-9 as having muscle tissue had this unusual kind only.
Most of the tumor-bearing mice were bled just prior to sacrifice, 
and their sera analyzed for the presence of a-fetoprotein (AFP). Figure 
3-15 presents an example of such an experiment, and the results of the 
analyses are given as the last lines in Tables 3-8 and 3-9. Three of 
the 13 PCT tumors tested, and one of 7 PCF tumors, produced detectable 
amounts of AFP; all four of the positive tumors were well-differentiated 
and contained substantial amounts of secretory endodermal epithelium.
As discussed above, the best evidence suggests that AFP is not synthe­
sized by ECCs, but rather by endodermal derivatives, including visceral 
yolk sac. The good correlation in these hybrid tumors between AFP 
secretion and the presence of endodermal derivatives adds further 
support to the hypothesis that these differentiated cells are responsible 
for AFP production in teratomas. The presence of AFP in the sera of 
tumor-bearing mice suggests that structural differentiation in the 
hybrid cells was accompanied by appropriate functional changes.
PART 3F: PCT cells lack Thy-1 (theta) antigen
Thy-1 antigen (previously called "theta") is an alloantigen first 
defined on thymocytes (Reif and Allen, 1964a,b), and subsequently 
demonstrated to be present on some brain cells, epidermal cells, thymus- 
processed lymphocytes (for review, see Greaves et al., 1973) and some 
fibroblast lines (Stern, 1973). ECCs do not have Thy—1 antigen
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Figure 3-15
Discontinuous counterimmunoelectrophoretic detection of a-fetoprotein. 
Top row: rabbit antiserum to mouse a-fetoprotein, diluted 1:4.
Bottom row: Antigen: serum or ascitic fluid from a mouse
carrying the indicated tumor; diluted 1:4.
1) T8-3
2) T7-1
3) OTT 6050 embryoid bodies (ascitic fluid; positive control.)
4) T3-1
5) 971 (nude mouse carrying a fibrosarcoma hybrid tumor;
negative control.)
6) OTT 6050 embryoid bodies (serum; positive control.)
7) T10-2
8) T13-2
9) T13-1
Wells 3, 4, 6, and 7 are positive for a-fetoprotein.
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detectable by immunofluorescence (Stern et al., 1975). As mentioned 
above, Thy-1 antigen has been shown to be extinguished when normal 
thymocytes (Parkaan and Merler, 1973) or thymic leukemia cells (Liang 
and Cohen, 1975) have been hybridized with Thy-1 fibroblasts.
PCT hybrid cells were examined for Thy-1 alloantigen by a cyto­
toxic absorption test. Since both 129/Sv and C3H/HeJ animals carry 
the Thy-1^ allele, which produces Thy-1.2 antigen, an AKR/J-anti- 
C3H/HeJ thymocyte serum, produced and titred as described above, was 
used in a cytotoxic absorption test (see Part 2K) using C3H/HeJ 
thymocytes as target cells. Each PCT clone was tested 5 times; Table 
3 - 1 0 shows the result of a representative experiment.
Each aliquot of absorbed serum was divided into two portions, 
which were then tested independently for cytotoxic activity. In the 
experiment presented in Table 3-10, the two portions of AKR/J-thymocyte- 
absorbed serum killed 792 and 802 of the 100 cells counted. The table 
records the mean of these "2 killed" scores, as well as the standard 
error of the mean. The cytotoxic index, calculated as described in 
Part 2K above, shows that AKR-absorbed serum killed 792 of the 
thymocytes excluding those killed by C' alone; the value of 902 residual 
cytotoxicity indicates that this AKR-absorbed serum had a cytotoxic 
index 902 of that for unabsorbed serum tested on the same, day.
The table shows that (C3H/HeJ x 129/Sv)mouse thymocytes, as 
expected, removed all of the Thy-1 cytotoxic activity from the serum. 
Three of the PCT hybrid clones removed about as much activity as did 
AKR thymocytes; the fourth clone, PCTBla, removed somewhat more in this 
particular test, though not in replicate experiments. All four PCT 
clones repeatedly removed small amounts of cytotoxic activity, usually
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TABLE 3-10
CYTOTOXIC ABSORPTION TEST FOR THY-1.2 ANTIGEN
Mean
Absorbed With % Killed
AKR/J thymocytes 79.5
C12F^ thymocytes 4.5
PCTA1 77.0
PCTA2 80.0
PCTBla 54.5
PCTBlb 80.5
Cytotoxic Residual
S.E.M. Index Cytotoxicity
0.5 79 90
0.5 0 0
3.0 76 86
3.0 79 90
5.5 52 59
1.5 80 91
Unabsorbed serum 89.0 1.0 88 (100)
No serum; C' only 4.5 2.5 (0)
Two volumes of serum diluted 1:1600 were absorbed with one 
volume of packed cells. Further experimental details are given 
in the text. 'Talues in parentheses are assigned by definition. 
= (C3H/HeJ x 129/Sv)Fr
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to about the sane extent as did AKB/J thymocytes. Since AKR/J mice 
£
carry the Thy-1 allele, and are hence unable to produce Thy-1.2 
antigen, the small amount of antibody they absorb from the serum is 
likely unrelated to the Thy-1 system. (The antiserum was not produced 
in congenic mice, and thus may very well include antibodies specific 
for other antigens.) It is possible that the PCT cells exhibit a very 
small amount of Thy-1.2 antigen, or, more likely, that they absorb 
small amounts of the other specificities detected by the AKR-anti-C3H 
serum. They clearly produce much less Thy-1 antigen than thymus cells 
from hybrid mice.
Dr. K. Kano (S.U.N.Y., Buffalo, N.Y.) has also tested these cells, 
in his laboratory and using different antisera, for the presence of 
Thy-1.2 antigen. Neither PCC4azal nor any of the four PCT clones had 
Thy-1 antigen detectable either by absorption or mixed hemagglutination 
tests.
PART 3G: PCT cells exhibit H-2 antigens
Although most mouse cells, including thymocytes, exhibit H-2 
antigens on their surface (for review, see Klein, 1975), embryonal 
carcinoma cells are said not to; antibody-mediated cytotoxic tests 
(Artzt and Jacob, 1974) and immunofluorescence (Stem et al., 1975) 
have both been shown not to detect H-2 on ECCs. The PCT hybrid clones 
and their PCC4azal parent were therefore tested to see whether they 
could absorb cytotoxic anti-H—2 antibodies. Since the parental genomes 
differed at the H-2 loci (129/Sv carries haplotype be, which is serol­
ogically indistinguishable from b, and C3H/HeJ carries haplotype k),
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it was possible to look for the independent expression of H-2 genes 
from either genome. The antisera used and the procedure employed have
|)C
been discussed above; as susaaarized in Table 2-1, the test for H-2 
utilizes a serum directed against the private specificity, 33, shared 
by the and K?*c antigens (as well as against several public speci- 
ficities not present on K or D ;, while the anti-H-2 test employs a 
serum which will react against the private specificity, 23, present on
It
the K molecule, and against several public specificities.
Table 3-11 presents the results of several experiments in which 
the anti-H-2 serum was absorbed with 0.5 volumes of packed PCT (or 
control) cells, and then split into two portions which were tested on 
810.BR mesenteric lymph node cells for residual cytotoxic activity. 
Unabsorbed serum, by definition, had a residual cytotoxicity of 100. 
Serum absorbed with A9 cells (transformed C3H/HeJ fibroblasts; H-2^) 
had a residual cytotoxicity of 6 (data not shown). As expected,
PCC4azal and F9 cells do not absorb H-2 antibodies, since these cells 
do not carry this haplotype. All four PCT hybrid cell lines absorb 
significant amounts of anti-H-2 cytotoxic activity. The rightmost 
column of Table 3-11 shows the result of a statistical test of the 
hypothesis that the cell line in question absorbs the same amount of 
cytotoxic activity as PCC4azal. As evaluated by Student's t-test 
(Snedecor and Cochran, 1967), all four PCT cell lines differ from 
PCC4azal in this respect, at the p<.01 significance level. Furthermore, 
although the 95% confidence intervals for mean residual cytotoxicity 
include 100 for F9- and PCC4azal-absorbed serum, the intervals for 
three of the four PCT hybrid lines do not include 100; this data is 
also included in Table 3-11. (The first of these tests is the more
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TABLE 3-11
H-2 ANTIGEN IN PCT HYBRID CELLS AND CONTROLS
Cell Line Mean RC S.E.M. 95% Limits N
t-statistic 
(vs. PCC4azal)
PCC4azal
F9
107
109
7
14
77-137
49-169
3
3 .12
PCTA1
PCTA2
PCTBla
PCTBlb
17
27
20
3
7
7
10
4
0-47
0-57
0-147
0-20
3
3
2
3
9.14**
8.28**
7.86**
13.56**
For each cell line, the results of N separate assays (each involving 
duplicate determinations) were averaged to give a mean residual cytotox­
icity (Mean RC), which is a cytotoxic index expressed as a percentage of 
that found for unabsorbed serum in the same test. S.E.M. gives the 
standard error of this mean, and the limits of the 95% confidence interval 
for the mean are also given. The rightmost column shows the t-statistic 
computed to test the hypothesis that the cell line in question differs from 
PCC4azal in Mean RC. (**) indicates that all four PCT clones differ from 
PCC4azal in this respect at the p<.01 confidence level.
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convincing, since the absorption of snail but significant amounts of 
activity could be ascribed to serum dilution by diluent trapped in the 
cell pellet, or to non-specific binding; but these effects, if present, 
are likely to have affected negative control cells as well.) On 
average, the unabsorbed antiserum, at the dilution used, killed about 
70% of the target cells in these tests; PCT absorbed sera, on average, 
killed about 20-30% of the B10.BR targets. When these values are 
compared to the titration curve for D3b serum (not shown), one finds 
that PCT absorption removes between 50-70% of the cytotoxic antibody. 
Since the largest portion of antibody in D3b serum seems likely to be 
directed against classical H-2 antigens (and not, for example, la 
antigens), we can conclude that PCT cells probably exhibit K^.
The expression of H-2 antigens on the surface of cells of all 
four PCT clones has been confirmed by K. Kano using a mixed hemaggluti­
nation technique (K. Kano, personal communication).
beTable 3-12 presents the results of similar tests for H-2
antigen. Three control cell lines were tested: A9 and FBU do not
becarry the genes for H-2 antigens, and F9, though from a 129/Sv mouse, 
has been shown not to express H-2 antigens (Artzt and Jacob, 1974).
As expected, the 95% confidence interval for the mean residual cytotox­
icity of each line includes 100; F9-absorbed serum, in three tests, 
retained 95.7% (±2.8% standard error of the mean) of the cytotoxic 
activity present in unabsorbed serum tested at the same time.
PCC4azal, and three of the PCT hybrid clones, absorbed statistical­
ly significant (though very small) amounts of cytotoxic activity from 
D33 antiserum tested on C57BL/10 mesenteric node lymphocytes; the 95% 
intervals for these three cell lines do not include 100. PCTA1 and
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TABLE 3-12
H-2b ANTIGEN IN PCT HYBRID CELLS AND CONTROLS
Cell Line Mean RC S.E.M. 95% Limits N
t-statistic 
(vs. F9)
A9 103 3.5 59-147 2
FBU 98 6.6 77-119 4 --
F9 96 2.8 84-108 3 --
PCC4azal 83 4.9 69-97 5 1.81
PCTA1 71 3.4 56-86 3 5.50**
PCTA2 76 8.3 40-112 3 2.18
PCTBla 76 5.0 60-92 4 3.17*
PCTBlb 84 4.6 69-99 4 1.95
For each cell line, the results of N separate assays (each involving 
duplicate determinations) were averaged to give a mean residual cytotox­
icity (Mean RC), which is a cytotoxic index expressed as a percentage of 
that found for unabsorbed serum in the same test. S.E.M. gives the 
standard error of this mean, and the limits of the 95% confidence interval 
for the mean are also given. The rightmost column shows the t-statistic 
computed to test the hypothesis that the cell line in question differs from 
F9 in Mean RC. (**) indicates significance at the p<0.01 level;
(*), at the p<0.05 level.
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PCTBla absorbed more antiserum than negative control F9 cells, as
tested by Student's t-test, at the levels of significance indicated
in the table. The other two PCT lines and PCC4azal may have absorbed
more antibody than F9 cells, but not significantly more.
When changes in the proportions of target cells killed are compared
with the titration curve for this cytotoxic system, it is clear that
absorption with PCT or PCC4azal cells removes less than half of the
serum's cytotoxic activity. It seems possible, therefore, that the
antibodies removed by these cells could be "contaminating" molecules
not directed against the classical H-2 antigens themselves. From this
beperspective, what seems to be low-level expression of H-2 might re­
flect the limitations in specificity of our cytotoxic system.
PCT and PCC4azal cells are pluripotent; PCT cultures, especially, 
sometimes contain small clusters of morphologically differentiated
cells. It is possible that a small proportion of the cells in the
becultured populations exhibit H-2 , but that the majority of cells lack
bethis antigen. Small amounts of H-2 have been demonstrated on PCC4 
cells under some culture conditions (K. Artzt, personal communication). 
Heterogeneity of antigen expression in these cells could be evaluated 
by immunofluorescence.
PCT cells absorb more cytotoxic activity from the anti-H-2 serum used
than from the anti-H-2^ serum. Although it is possible that these cells
k beactually express more H-2 product (from the thymocyte genome) than H-2
(from the teratocarcinoma genome), the tests presented in this thesis do
not prove this. The two sera may, for example, differ in a) the number
of different antigenic determinants recognized; b) the concentrations
of antibody specific for each determinant; and c) the distribution
of cytotoxic activity among the individual antibody species.
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It is also possible that tke two target cell populations might differ 
in susceptibility to C'. It is thus impossible to infer a simple re­
lation between mean residual cytotoxicity values and numbers of H-2 
molecules produced by the absorbing cell.
Two of the PCF lines (PCFA8 and PCFB2) absorb significant amounts 
of anti-H-2^ activity as well, but these lines have not been studied 
as extensively, and the data will not be presented here.
PART 3H: PCF cells resemble PCC4azal enzymatically
FBU and PCC4azal cells differ in their levels of two enzymes 
(besides alkaline phosphatase, which has been discussed above): FBU
cells have high levels of acetylcholinesterase (E.C. 3.1.1.7; AChE), 
and PCC4azal cells express the "B" allele of lactate dehydrogenase 
(E.C. 1.1.1.27; LDH), as well as the LDH-A allele (which both parents 
express). All five PCF clones resemble PCC4azal in both respects.
Auerbach and Brinster (1967) have reported that pre-implantation 
mouse embryos, from the oocyte stage to that of the 5th-day blastocyst, 
contain LDH-1 (i.e., only B subunits) to the virtual exclusion of the 
other LDH isozymes (which contain some of the A subunit). Shortly after 
implantation, however, the LDH pattern changes radically, so that by 
day 7, and until day 12, 90% of the LDH in the embryo and its protective 
membranes is LDH-5, which contains only A subunits. When implantation 
is delayed hormonally, the changeover in LDH pattern was similarly 
delayed, although the blastocysts were not otherwise damaged and re­
tained the ability to implant when the hormonal treatment was over.
This result suggests that the synthesis of LDH-A subunits is linked to
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Implantation per se.
As shown in figure 3-16, PCC4azal cells synthesize both LDH-A and 
LD5-B, and, in this respect, resemble neither cells of pre-inplantation 
embryos nor of the early post-implantation stages. The LDH pattern of 
embryonal carcinoma cells other than those long since adapted to 
culture has not, to my knowledge, been reported.
FBU cells, as shown in figure 3-16, express only LDH-A. PCF 
hybrid cells, like PCC4azal, express both A and B alleles, though more 
A than B is produced by both the hybrid and parental cells.
Acetylcholinesterase is present in erythroid cells, including 
mature erythrocytes (Galehr et al., 1928) and Friend erythroleukemia 
cells (Conscience et al., submitted for publication). As shown in 
Table 3-13, PCF hybrid cells and PCC4azal ECCs contain less than 1% of 
the AChE activity found in the FBU parents.
PART 31: Globin gene expression in PCF hybrid cells
Many groups (see review in Friend et al., 1974) have shown that 
cultures of most Friend erythroleukemic cell lines have levels of 
globin mRNA which, while low in comparison to the levels found in DMSO- 
treated cultures, are much higher than the amounts present in non- 
erythroid cells. Uninduced Friend cell cultures also typically contain 
a proportion of hemoglobinated, and hence benzidine-positive cells.
This fraction varies between 0.1-5.02; the factors responsible for the 
variation are not understood. FBU cultures assayed at different times 
and in different labs have been shown to contain between 0.00022-1.0% 
benzidine—positive cells (Skoultchi, Conscience, and Fournier, personal
‘•a>nw>
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Figure 3-16
Lactate dehydrogenase isozymes in PCF hybrids and controls.
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TABLE 3-13
ACETYLCHOLINESTERASE IN PCF HYBRID CELLS AND CONTROLS
Mean
Cell Line Specific Activity S.E.M.
FBU 3900. 20.
PCC4azal 13.1 20.9
PCFA8 -1.6 2.1
PCFB1 5.3 1.8
PCFB2 26.0 1.0
PC^BS 9.1 2.9
PCFB5 6.8 1.3
Specific activities are given in pmoles acetylcholine hydrolyzed 
per minute at 20° per mg protein, and represent the mean of 2 assays, 
each done in duplicate on different days.
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communication, and my own unpublished results). Uninduced FBU cultures 
also contain immunologically detectable hemoglobin, and globin mRNA as 
measured by nucleic acid hybridization (Skoultchi eit al., submitted 
for publication).
The most sensitive of these tests for globin gene expression is 
the assay for globin mRNA. Preliminary results from a collaborative 
study (Skoultchi, Miller, and Ruddle, in preparation) show that all five 
PCF clones contain globin mRNA, in amounts which are much lower than 
those characteristic of FBU cells, but higher than the (undetectable) 
levels of Friend cell x fibroblast and Friend cell x hepatoma hybrids. 
PCC4azal cells contain little or no globin message. Growth of PCF cells 
in DMSO causes a small diminution of globin mRNA levels.
To rule out the suggestion that these low globin mRNA levels might 
be the product of a small proportion of hemoglobinated cells in an 
otherwise "non-erythroid" population, I have examined all five clones 
of PCF cells, without prior DMSO treatment, for the presence of 
benzidine-positive cells. In excess of 105 cells of each clone were 
scanned, and no hemoglobinated cells were found. FBU cultures tested 
as positive controls were found to contain positive cells. After four 
days of growth in medium containing 1.52 DMSO, FBU cultures typically 
contain about 45% hemoglobinated cells. PCFA8 and PCFB5 cultures, on 
the other hand, were found not to contain any positive cells (<10~"*) 
after four days of growth in DMSO.
The mRNA data, together with the benzidine assays, suggest that 
many of the cells in each PCF clone may be expressing the globin gene 
at a very low level. More extensive control studies, particularly to 
see if globin mRNA is produced at all in PCC4azal and PCT hybrid cells,
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are in progress. Regardless of their outcome, it is clear that globin 
gene expression in PCF hybrids is severely depressed in comparison to 
expression in the Friend cell parent.
PART 3J: Summary of results
1 summarize here, for convenience, the properties of the PCT and 
PCF hybrid cell lines, and compare them with those of the parental cell 
lines. Table 3-14 pertains to the PCT series, and Table 3-15 to the 
PCF cells.
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TABLE 3-14
SUMMARY: PROPERTIES OF PCT HYBRID CELLS AND CONTROLS
Property
PCC4azal
Chromosome number 
Growth
Extranucleolar
heterochromatin
Alkaline phosphatase1
MVM infection
Tumors
Thy-1 antigen 
H-2 (note c)
H-2^ (note c)
39
attached clumps
very little 
4 units 
resistant 
teratoid 
no
? present 
not present
Thymocytes PCT Hybrids
40
suspension
moderate
0.5 units 
b
yes
not present 
present
73-75
attached clumps
very little 
2-4 units 
resistant 
teratoid 
no
present (2 clones) 
present
Notes: a) Chromosome numbers and enzyme activities are means.
b) Thymocytes could not be tested for MVM susceptibility since they do not divide
mitogen-stimulated T lymphocytes are, however, resistant to MVM.
c) H-2 levels are estimated from massive absorptions, and require further
exploration by single cell technqiues and quantitative absorptions, 
as noted in the text.
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TABLE 3-15
SUMMARY: PROPERTIES OF PCF HYBRID CELLS AND CONTROLS
PCC4azal FBU PCF Hybrids
Chromosome number 
Growth
Extranucleolar
heterochromatin
Alkaline phosphatase
MVM infection
Tumors
LDH Isozymes 
Acetylcholinesterase 
Benzidine stain
39
attached clumps
very little 
7 units 
resistant 
teratoid 
A and B 
13 units 
negative
39
suspension
moderate
<0.1 unit
susceptible
erythroleukemia
A only
3900 units
positive
70-73 or 94-107 
attached clumps
very little 
7-11 units 
resistant 
teratoid 
A and B 
0-26 units 
negative
Note: Chromosome numbers and enzyme activities are means.
CHAPTER FOUR: DISCUSSION
The results of my research, which have been summarized in Part 3J 
above, show that somatic cell hybrids of embryonal carcinoma cells can 
closely resemble their ECC parent, even to the retention of pluripo- 
tency. Yet experiments in other laboratories, especially the studies 
of Finch and Ephrussi (1967), Jami et al. (1973), and McBuraey (1976), 
have shown that teratocarcinoma x fibroblast hybrids resemble fibro­
blasts (see Part 1G, above). How can one explain this apparent dis­
crepancy?
Four classes of explanation come to mind. For one thing, PCT and 
PCF hybrid cells differ from previously studied teratocarcinoma-derived 
hybrids in the proportion of chromosomal material contributed to the 
hybrid by the teratoma and non-teratoma parents. This "gene dosage" 
effect on hybrid phenotype has been discussed in Part 1A, above. The 
three parental cell types used to produce PCT and PCF hybrids have 39 
or 40 chromosomes each, with 40-43 chromosome arms. The fibroblast 
parents used in the three previous published reports contained 50-68 
chromosomes, many of them bi-armed (in the L cell derivatives). It 
would be interesting in this regard to produce and test hybrids between 
PCC4azal and tetraploid Friend cells, or between PCC4azal and two 
Friend or thymus cells. As mentioned above, McBurney (1976) has shown 
that fusion between a tetraploid ECC and a subtetraploid 3T3 cell 
yields fibroblastoid hybrids.
A second possibility is that L cells and 3T3 cells, during their 
long history of growth in vitro, may, in the process of selection for 
fast-growing cells, have also acquired an unusually strong ability to
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control the phenotype of somatic cell hybrids. Mere tumorigenicity is 
not sufficient to endov a cell with thin (so far hypothetical) ability: 
Friend cells (including FLC, the line from which FBU was derived) are 
tumorigenic. It is possible that extensive karyotypic evolution is 
more important than tumorigenicity per se.
The discrepancy between my results and the earlier findings might
also be due, in part, to technical considerations. It is difficult to
tell whether the cloned, pluripotent teratocarcinoma cultures used in
some of the previous studies may have contained "contaminating"
teratoma-derived fibroblasts, as do many such cultures (Lehman et al.,
«
1974; Martin and Evans, 1974). In my experience, embryonal carcinoma 
cultures have seemed to produce hybrids in low yield, relative to other 
cultured cell types, and it is possible that fibroblasts in a mixed 
teratocarcinoma culture might give rise to hybrid clones at rates 
disproportionate to their representation in the culture. Furthermore, 
the hybridizations reported by Finch and Ephrussi (1967) and by Jami 
et al. (1973) were carried out under semi-selective conditions; embry­
onal carcinoma cells were not killed, and hybrid colonies were selected 
for study because they contained fibroblastoid cells. It is possible 
that these two hybridization experiments produced pluripotent hybrids 
which were not recognized because they, like PCT and PCF cells, looked 
like their ECC parents under phase microscopy. (Similarly, it is 
possible that the PCC4azal x thymocyte fusion mixtures contained hybrid 
cells which so closely resembled thymocytes that they failed to grow 
under routine culture conditions. This possibility is in no way ruled 
out by my failure to recover proliferating suspension cells.) These 
considerations are unlikely to apply to the study of McBumey (1976),
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who used ECC lines derived by a technique, cloning on feeder layers, 
which minimizes differentiation (Martin and Evans, 1975a), and used 
selective conditions which killed both parental lines.
A more intriguing explanation of the results reported in this 
thesis might be that differences between PCT and PCF hybrids and the 
teratoma-fibroblast hybrids are due not to gene dosage, or peculiarities 
of culture-adapted lines, or technical artifact, but rather to inherent 
differences between fibroblasts and Friend or thymus cells. The first 
step in exploring this suggestion is to ascertain whether any or all 
of the products of fusion between ECCs and normal diploid fibroblasts 
are pluripotent. If they are, then the results reported from other 
laboratories can be attributed to one or more of the three factors 
listed above. But if hybrids between ECCs and diploid fibroblasts do 
resemble their fibroblast parents, this will suggest that fibroblasts 
may differ from both Friend cells and thymocytes in the details of the 
mechanisms they use to maintain their respective differentiated states. 
This suggestion could be explored by cell fusion experiments in which 
fibroblasts were compared with Friend and thymus cells with respect 
to their aptitude for influencing hybrid phenotypes in confcination with 
parents other than embryonal carcinoma cells.
We must also consider the idea that the PCT and PCF hybrids might 
resemble teratocarcinomas only because they may have lost large or 
particularly important parts of the genetic material contributed by the 
non-pluripotent parent. Several previous experiments (reviewed in 
Darlington and Ruddle, 1975) have suggested that retention or re­
acquisition of a cell-specific characteristic may be contingent on the 
loss of chromosomes from the parent which did not show the trait in
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question; in at least two instances (Wiener et al., 1972; Cochran 
et al., 1975), tumor morphology was affected in this way. It is 
possible that each PCT line, for example, could have lost a small number 
of thymocyte-derived chromosomes which, if retained, would have forced 
retention of thymus-specific traits, but which do not include the 
chromosomes coding for GPI or H-2. It is also conceivable that a large 
number of thymus-derived chromosomes have been lost, but have been re­
placed by morphologically indistinguishable PCC4azal chromosomes. These 
matters cannot be decided with available genetic or cytogenetic methods. 
The three 2:1 PCF hybrids do lose chromosomes with continued culture; 
there is no evidence from these clones on the issue of preferential 
loss of genetic material from one parent or the other.
Cultured cell lines derived from PCT hybrid tumors show chromosome 
loss ranging from moderate (in one tumor, 7 of 75 chromosomes lost) to 
undetectable in the other three tumors examined. All four tumors re­
tained both alleles of GPI. There is thus no evidence, at this limited 
resolution, for chromosome loss accompanying tumor formation in PCT 
hybrid cells.
My studies of the properties of PCT and PCF hybrid cells suggest 
a generalization: that fusions between embryonal carcinoma cells and
near-diploid non-pluripotent cells produce hybrids which resemble ECCs. 
This hypothesis clearly requires further testing; hybrids involving 
other ECC lines and other differentiated cell lines should be charac­
terized to define the limits over which this generalization applies.
Should this phenomenon prove to be general, it would suggest that 
ECCs, and perhaps the embryonic mesectodermal precursor cells they so 
closely resemble, contain a molecular apparatus able to "reset" the
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genome of committed and differentiated cells. Precedent for such a 
phenomenon can be found in the work of Gordon and his collaborators 
(reviewed la Gordon, 1974), who showed that differentiated amphibian 
nuclei could, if placed into an enucleated oocyte, revert to a totipo­
tent state and carry out the normal developmental program. Similar 
work has been carried out by Ulmensee (1973) in Drosophila. The work 
presented in this dissertation is not completely analogous, since the 
PCC4azal nuclei have not been removed, nor the Friend and thymus cell 
nuclei shown to be entirely reprogrammed. It is possible, for example, 
that the Friend and thymus cell genetic material in these hybrids, 
while no longer making any of the gene products characteristic of these 
cell types, and while still producing the constitutive enzymes and 
antigens I have tested for, is for some reason incapable of making ECC- 
specific products. Nor have Friend or thymus cell chromosomes been 
shown to participate directly in the developmental transitions of which 
these hybrids are capable. These results therefore raise a number of 
questions:
1) Do the thymic and erythroid genomes "convert" to pluripotency, 
or are they merely neutralized, expressing only those genes which are 
expressed in both parents?
2) If PCC4azal cells can reset other genomes, how, in molecular 
terms, is this accomplished? Is PCC4azal cytoplasm sufficient to reset 
a differentiated nucleus? Is a PCC4azal nucleus sufficient to reset 
the cytoplasm from some other cell type, and, if so, does this depend 
on the position of either parent in the cell cycle?
3) Is this reprogramming ability, hypothesized to be present in 
PCC4azal cells, present in all embryonal carcinoma cells, and in
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embryonic oesectodermal precursor cells? If so, when is it lost: be­
fore, or after the pluripotent ECC commits Itself to a particular line 
of differentiation?
These problems have still to be resolved. In any case, these 
experiments show that embryonal carcinoma cells, although nearly unre­
stricted in their developmental potential, can nonetheless control the 
pattern of gene expression in a somatic cell hybrid whose other parent 
is a stably differentiated cell. The ability (of ECCs) to give rise 
to a variety of differentiated progeny under appropriate developmental 
conditions does not necessarily bring with it a susceptibility to what­
ever factors those differentiated cells use to maintain their epigenetic 
state.
The work reported here bears upon three other, more specific issues 
as well. I want first to discuss the relevance of my work to extinction 
of Friend cell properties in somatic cell hybrids. As summarized above 
in Part 1C, the previous work on Friend cell hybrids is equally compat­
ible with either of two hypotheses: first, that erythroid properties
are extinguished whenever Friend cells are fused with non-erythroid 
cells; or, second, that extinction takes place whenever the non-erythroid 
parent contributes the majority of chromosomes to the hybrid cells. (It 
may well be, of course, that total chromosome number is less important 
than the doses of a few particular loci.) PCFB3 and PCFB5 are likely 
to contain about equal genetic contributions from FBU and PCC4azal, but 
resemble the latter parent closely. In at least this case, then, 
addition of but a single diploid genome from a non-erythroid cell is 
sufficient to extinguish the erythroid-specific properties of FBU. It 
is hard to predict the properties of hybrids containing twice as much
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genetic material from Friend cells as from an ECC.
My results are relevant also to the question of antigen expression 
on ECCs. Previous studies, reviewed in Part IF, have suggested that
! ECCs lack detectable H-2 antigen, but exhibit ECC-specific antigen or
j
antigens, one of which (F9 antigen) is chemically similar to H-2
and probably coded for by an allele of the T/t complex. Ideally, one
| would wish to characterize the surface antigens of the PCT and PCF
I!
hybrids in a number of ways, including 1) massive absorptions to test 
whether the hybrid populations had any cell surface H-2 antigen; 2)flu­
orescent antibody tests to see whether all the cells exhibit the same 
antigens; 3) quantitative absorptions to see how much of each antigen 
was present, expressed relative to a standard absorbing cell, such as 
a lymph node cell from an F^ hybrid mouse; and 4) tests for ECC-
specific antigens. At present, only the first of these steps has been
completed, and only for the PCT cells; conclusions about surface anti­
gen patterns of these hybrids are therefore necessarily limited.
The data show that all four PCT hybrid populations can absorb
1c
cytotoxic activity directed against the H-2 allele contributed by the
thymocyte parent. Three of the four clones, and PCC4azal cells as
b
well, also remove cytotoxic activity from an anti-H-2 serum, and two 
of the PCT hybrids removed significantly more than a negative control 
line, F9. (H-2*5 is serologically indistinguishable from H-2^c, the
antigen of the 129/Sv strain from which the ECC line was derived.)
More cytotoxic activity is removed from the anti-H-2 serum than from
the anti-H-2^ serum. As discussed above (Part 3K), this result suggests
It b othat these cells may exhibit more H-2 molecules than H-2 , but other
explanations are possible and have not been ruled out.
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The results suggest as veil that expression of H-2 antigen is 
compatible with pluripotency. But another hypothesis, that some of 
the cells in each hybrid population have begun to express H-2 while 
losing pluripotency, can only be ruled out by single-cell tests for 
population heterogeneity.
The third specific issue I want to discuss concerns the co-ordina­
tion of properties usually expressed together on embryonal carcinoma 
cells. Among the many events that occur during the seventh day of mouse 
embryonic development, three seem especially relevant here. Ectopically 
transplanted embryos are able to produce teratocarcinomas only up to 
the seventh day of gestation; transplantation of older embryos produces 
only embryomas, devoid of ECCs and hence not transplantable from animal 
to animal (Damjanov et al., 1971c). Secondly, early embryos placed 
under the kidney or testis capsules develop more or less normally only 
up to the seventh day stage, at which point disorganization begins, 
culminating in teratoma formation (Stevens, 1968; 1975). Finally, this 
stage is also the earliest at which H-2 antigen can be defected (re­
viewed in Billington and Jenkinson, 1975). Although these three changes 
occur approximately at the same embryonic stage, it has yet to be shown 
that they in fact take place simultaneously. One ought, however, to 
consider the possibility that these transitions do occur together, and 
do so for a reason.
Embryonal carcinoma cells have a cluster of properties, each of 
which is found in few if any other cell types. As discussed in the 
introduction to this dissertation, ECCs are a) totipotent; b) nontu- 
morigenic in one environment, the inner cell mass, but able to produce 
tumors elsewhere; c) low in H-2 antigen but high in chemically similar,
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ECC-specific antigens; and d) resistant to a number of viruses to which 
many mouse cells are susceptible. They also have a number of properties 
which surprise us less (unusual chromatin distribution, characteristic 
enzyme activities, particular adhesive properties, etc.), but which 
may nonetheless have important developmental implications. Some of 
these properties may be contingent on others; for example, and for 
reasons that are not yet obvious, susceptibility to SV40 infection may 
be incompatible with totipotency, or with F9 antigen expression.
Somatic cell hybridization provides an opportunity to dissect such 
an association of properties epigenetically. The studies of Minna 
et al. (1972) and of Szpirer and Szpirer (1975) have provided surprising 
glimpses of control mechanisms in neuroblastoma and hepatoma cells, 
respectively. If an ECC-Friend cell hybrid, for example, were shown to 
be pluripotent, but yet MVM-susceptible, one could conclude that what­
ever metabolic specializations endowed cells with resistance to MVM 
were incidental, rather than fundamental, to the totipotent state.
All the PCT and PCF hybrid clones resemble embryonal carcinoma 
cells in each of the properties tested— enzymatic, viral, developmental, 
and antigenic— -with the likely exception of the H-2 antigens discussed 
just above. Tl^ few structural differences found (e.g. nucleolar 
number in the hybrids is usually greater than in the PCC4azal parents, 
and cell size is also somewhat larger) may be due simply to the greater 
ploidy of the hybrids; nucleolar number of tetraploid, pluripotent ECCs 
has not, to my knowledge, been reported. The marginally higher content 
of globin mRNA sequences in PCF cells, as compared to other Friend cell 
hybrids and to PCC4azal controls, may be a more significant exception, 
and is still under investigation (Skoultchi, Miller, and Ruddle, in
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preparation). Continued association of all these ECC properties In 
two kinds of hybrids clearly does not prove that any of the traits 
depends on any of the others, such less reveal the nature of the link. 
Dissociation may be brought about in other hybrid combinations, or in 
some other kind of experiment altogether. The most one can say is 
that the intertypic hybridizations reported here provide no evidence 
that any of the ECC-specific properties can be expressed (or extin­
guished) independently of the vhole set.
This discussion has encompassed a fair number of still-unansvered 
questions. I wish to close by mentioning one other avenue for future 
exploration. It will soon be routine to transfer portions of the 
human genome, ranging in size from the entire diploid set, to individual 
chromosomes, to small sections of chromosomes, and at high efficiency, 
into any mouse cell which lacks HGPRT. The results presented in this 
dissertation make it seem likely that at least some of the resultant 
partial hybrids will be pluripotent. It is likely, too, that these 
cells will produce the enzymes, antigens (including human "T/t" anti­
gens), etc., characteristic of the early and inaccessible stages of 
human embryogenesis, and hence not easy to obtain in other ways. 
Furthermore, it is not at all impossible that these partial hybrids, if 
injected into the blastocyst cavity of early mouse embryos, will par­
ticipate in the formation of a mosaic mouse. It would be interesting,
I think, to see how the human genes which mediate such embryonic 
decisions as growth rate, size, germ layer orientation, etc., in which 
mouse and human embryos differ, would interact with the intact mouse 
genome in these "embryogenic" hybrid cells.
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